id	sid	tid	token	lemma	pos
ajlm-806	1	1	abstract	abstract	ADJ
ajlm-806	1	2	introduction	introduction	NOUN
ajlm-806	1	3	methods	method	NOUN
ajlm-806	1	4	results	result	VERB
ajlm-806	1	5	discussion	discussion	NOUN
ajlm-806	1	6	acknowledgements	acknowledgement	NOUN
ajlm-806	1	7	references	reference	NOUN
ajlm-806	1	8	about	about	ADP
ajlm-806	1	9	the	the	DET
ajlm-806	1	10	author(s	author(s	PROPN
ajlm-806	1	11	)	)	PUNCT
ajlm-806	1	12	winnie	winnie	PROPN
ajlm-806	1	13	mwanza	mwanza	PROPN
ajlm-806	1	14	zambia	zambia	PROPN
ajlm-806	1	15	aids	aids	PROPN
ajlm-806	1	16	related	relate	VERB
ajlm-806	1	17	tuberculosis	tuberculosis	NOUN
ajlm-806	1	18	(	(	PUNCT
ajlm-806	1	19	zambart	zambart	NOUN
ajlm-806	1	20	)	)	PUNCT
ajlm-806	1	21	project	project	NOUN
ajlm-806	1	22	,	,	PUNCT
ajlm-806	1	23	school	school	NOUN
ajlm-806	1	24	of	of	ADP
ajlm-806	1	25	medicine	medicine	NOUN
ajlm-806	1	26	,	,	PUNCT
ajlm-806	1	27	university	university	PROPN
ajlm-806	1	28	of	of	ADP
ajlm-806	1	29	zambia	zambia	PROPN
ajlm-806	1	30	,	,	PUNCT
ajlm-806	1	31	lusaka	lusaka	PROPN
ajlm-806	1	32	,	,	PUNCT
ajlm-806	1	33	zambia	zambia	PROPN
ajlm-806	1	34	deborah	deborah	PROPN
ajlm-806	1	35	milimo	milimo	PROPN
ajlm-806	1	36	zambia	zambia	PROPN
ajlm-806	1	37	aids	aids	PROPN
ajlm-806	1	38	related	relate	VERB
ajlm-806	1	39	tuberculosis	tuberculosis	NOUN
ajlm-806	1	40	(	(	PUNCT
ajlm-806	1	41	zambart	zambart	NOUN
ajlm-806	1	42	)	)	PUNCT
ajlm-806	1	43	project	project	NOUN
ajlm-806	1	44	,	,	PUNCT
ajlm-806	1	45	school	school	NOUN
ajlm-806	1	46	of	of	ADP
ajlm-806	1	47	medicine	medicine	NOUN
ajlm-806	1	48	,	,	PUNCT
ajlm-806	1	49	university	university	PROPN
ajlm-806	1	50	of	of	ADP
ajlm-806	1	51	zambia	zambia	PROPN
ajlm-806	1	52	,	,	PUNCT
ajlm-806	1	53	lusaka	lusaka	PROPN
ajlm-806	1	54	,	,	PUNCT
ajlm-806	1	55	zambia	zambia	PROPN
ajlm-806	1	56	maureen	maureen	PROPN
ajlm-806	1	57	m.	m.	PROPN
ajlm-806	1	58	chilufya	chilufya	PROPN
ajlm-806	1	59	zambia	zambia	PROPN
ajlm-806	1	60	aids	aids	PROPN
ajlm-806	1	61	related	relate	VERB
ajlm-806	1	62	tuberculosis	tuberculosis	NOUN
ajlm-806	1	63	(	(	PUNCT
ajlm-806	1	64	zambart	zambart	NOUN
ajlm-806	1	65	)	)	PUNCT
ajlm-806	1	66	project	project	NOUN
ajlm-806	1	67	,	,	PUNCT
ajlm-806	1	68	school	school	NOUN
ajlm-806	1	69	of	of	ADP
ajlm-806	1	70	medicine	medicine	NOUN
ajlm-806	1	71	,	,	PUNCT
ajlm-806	1	72	university	university	PROPN
ajlm-806	1	73	of	of	ADP
ajlm-806	1	74	zambia	zambia	PROPN
ajlm-806	1	75	,	,	PUNCT
ajlm-806	1	76	lusaka	lusaka	PROPN
ajlm-806	1	77	,	,	PUNCT
ajlm-806	1	78	zambia	zambia	PROPN
ajlm-806	1	79	nkatya	nkatya	PROPN
ajlm-806	1	80	kasese	kasese	PROPN
ajlm-806	1	81	zambia	zambia	PROPN
ajlm-806	1	82	aids	aids	PROPN
ajlm-806	1	83	related	relate	VERB
ajlm-806	1	84	tuberculosis	tuberculosis	NOUN
ajlm-806	1	85	(	(	PUNCT
ajlm-806	1	86	zambart	zambart	NOUN
ajlm-806	1	87	)	)	PUNCT
ajlm-806	1	88	project	project	NOUN
ajlm-806	1	89	,	,	PUNCT
ajlm-806	1	90	school	school	NOUN
ajlm-806	1	91	of	of	ADP
ajlm-806	1	92	medicine	medicine	NOUN
ajlm-806	1	93	,	,	PUNCT
ajlm-806	1	94	university	university	PROPN
ajlm-806	1	95	of	of	ADP
ajlm-806	1	96	zambia	zambia	PROPN
ajlm-806	1	97	,	,	PUNCT
ajlm-806	1	98	lusaka	lusaka	PROPN
ajlm-806	1	99	,	,	PUNCT
ajlm-806	1	100	zambia	zambia	PROPN
ajlm-806	1	101	maina	maina	PROPN
ajlm-806	1	102	c.	c.	PROPN
ajlm-806	1	103	lengwe	lengwe	PROPN
ajlm-806	1	104	zambia	zambia	PROPN
ajlm-806	1	105	aids	aids	PROPN
ajlm-806	1	106	related	relate	VERB
ajlm-806	1	107	tuberculosis	tuberculosis	NOUN
ajlm-806	1	108	(	(	PUNCT
ajlm-806	1	109	zambart	zambart	NOUN
ajlm-806	1	110	)	)	PUNCT
ajlm-806	1	111	project	project	NOUN
ajlm-806	1	112	,	,	PUNCT
ajlm-806	1	113	school	school	NOUN
ajlm-806	1	114	of	of	ADP
ajlm-806	1	115	medicine	medicine	NOUN
ajlm-806	1	116	,	,	PUNCT
ajlm-806	1	117	university	university	PROPN
ajlm-806	1	118	of	of	ADP
ajlm-806	1	119	zambia	zambia	PROPN
ajlm-806	1	120	,	,	PUNCT
ajlm-806	1	121	lusaka	lusaka	PROPN
ajlm-806	1	122	,	,	PUNCT
ajlm-806	1	123	zambia	zambia	PROPN
ajlm-806	1	124	stembiso	stembiso	PROPN
ajlm-806	1	125	munkondya	munkondya	PROPN
ajlm-806	1	126	zambia	zambia	PROPN
ajlm-806	1	127	aids	aids	PROPN
ajlm-806	1	128	related	relate	VERB
ajlm-806	1	129	tuberculosis	tuberculosis	NOUN
ajlm-806	1	130	(	(	PUNCT
ajlm-806	1	131	zambart	zambart	NOUN
ajlm-806	1	132	)	)	PUNCT
ajlm-806	1	133	project	project	NOUN
ajlm-806	1	134	,	,	PUNCT
ajlm-806	1	135	school	school	NOUN
ajlm-806	1	136	of	of	ADP
ajlm-806	1	137	medicine	medicine	NOUN
ajlm-806	1	138	,	,	PUNCT
ajlm-806	1	139	university	university	PROPN
ajlm-806	1	140	of	of	ADP
ajlm-806	1	141	zambia	zambia	PROPN
ajlm-806	1	142	,	,	PUNCT
ajlm-806	1	143	lusaka	lusaka	PROPN
ajlm-806	1	144	,	,	PUNCT
ajlm-806	1	145	zambia	zambia	PROPN
ajlm-806	1	146	petra	petra	PROPN
ajlm-806	1	147	de	de	PROPN
ajlm-806	1	148	haas	haas	PROPN
ajlm-806	1	149	zambia	zambia	PROPN
ajlm-806	1	150	aids	aids	PROPN
ajlm-806	1	151	related	relate	VERB
ajlm-806	1	152	tuberculosis	tuberculosis	NOUN
ajlm-806	1	153	(	(	PUNCT
ajlm-806	1	154	zambart	zambart	NOUN
ajlm-806	1	155	)	)	PUNCT
ajlm-806	1	156	project	project	NOUN
ajlm-806	1	157	,	,	PUNCT
ajlm-806	1	158	school	school	NOUN
ajlm-806	1	159	of	of	ADP
ajlm-806	1	160	medicine	medicine	NOUN
ajlm-806	1	161	,	,	PUNCT
ajlm-806	1	162	university	university	PROPN
ajlm-806	1	163	of	of	ADP
ajlm-806	1	164	zambia	zambia	PROPN
ajlm-806	1	165	,	,	PUNCT
ajlm-806	1	166	lusaka	lusaka	PROPN
ajlm-806	1	167	,	,	PUNCT
ajlm-806	1	168	zambia	zambia	PROPN
ajlm-806	1	169	department	department	PROPN
ajlm-806	1	170	of	of	ADP
ajlm-806	1	171	infectious	infectious	ADJ
ajlm-806	1	172	and	and	CCONJ
ajlm-806	1	173	tropical	tropical	ADJ
ajlm-806	1	174	diseases	disease	NOUN
ajlm-806	1	175	,	,	PUNCT
ajlm-806	1	176	london	london	PROPN
ajlm-806	1	177	school	school	NOUN
ajlm-806	1	178	of	of	ADP
ajlm-806	1	179	hygiene	hygiene	NOUN
ajlm-806	1	180	and	and	CCONJ
ajlm-806	1	181	tropical	tropical	ADJ
ajlm-806	1	182	medicine	medicine	NOUN
ajlm-806	1	183	,	,	PUNCT
ajlm-806	1	184	bloomsburg	bloomsburg	PROPN
ajlm-806	1	185	,	,	PUNCT
ajlm-806	1	186	london	london	PROPN
ajlm-806	1	187	,	,	PUNCT
ajlm-806	1	188	united	united	PROPN
ajlm-806	1	189	kingdom	kingdom	PROPN
ajlm-806	1	190	helen	helen	PROPN
ajlm-806	1	191	ayles	ayle	VERB
ajlm-806	1	192	zambia	zambia	PROPN
ajlm-806	1	193	aids	aid	NOUN
ajlm-806	1	194	related	relate	VERB
ajlm-806	1	195	tuberculosis	tuberculosis	NOUN
ajlm-806	1	196	(	(	PUNCT
ajlm-806	1	197	zambart	zambart	NOUN
ajlm-806	1	198	)	)	PUNCT
ajlm-806	1	199	project	project	NOUN
ajlm-806	1	200	,	,	PUNCT
ajlm-806	1	201	school	school	NOUN
ajlm-806	1	202	of	of	ADP
ajlm-806	1	203	medicine	medicine	NOUN
ajlm-806	1	204	,	,	PUNCT
ajlm-806	1	205	university	university	PROPN
ajlm-806	1	206	of	of	ADP
ajlm-806	1	207	zambia	zambia	PROPN
ajlm-806	1	208	,	,	PUNCT
ajlm-806	1	209	lusaka	lusaka	PROPN
ajlm-806	1	210	,	,	PUNCT
ajlm-806	1	211	zambia	zambia	PROPN
ajlm-806	1	212	department	department	PROPN
ajlm-806	1	213	of	of	ADP
ajlm-806	1	214	infectious	infectious	ADJ
ajlm-806	1	215	and	and	CCONJ
ajlm-806	1	216	tropical	tropical	ADJ
ajlm-806	1	217	diseases	disease	NOUN
ajlm-806	1	218	,	,	PUNCT
ajlm-806	1	219	london	london	PROPN
ajlm-806	1	220	school	school	NOUN
ajlm-806	1	221	of	of	ADP
ajlm-806	1	222	hygiene	hygiene	NOUN
ajlm-806	1	223	and	and	CCONJ
ajlm-806	1	224	tropical	tropical	ADJ
ajlm-806	1	225	medicine	medicine	NOUN
ajlm-806	1	226	,	,	PUNCT
ajlm-806	1	227	bloomsburg	bloomsburg	PROPN
ajlm-806	1	228	,	,	PUNCT
ajlm-806	1	229	london	london	PROPN
ajlm-806	1	230	,	,	PUNCT
ajlm-806	1	231	united	united	PROPN
ajlm-806	1	232	kingdom	kingdom	PROPN
ajlm-806	1	233	monde	monde	PROPN
ajlm-806	1	234	muyoyeta	muyoyeta	PROPN
ajlm-806	1	235	zambia	zambia	PROPN
ajlm-806	1	236	aids	aid	NOUN
ajlm-806	1	237	related	relate	VERB
ajlm-806	1	238	tuberculosis	tuberculosis	NOUN
ajlm-806	1	239	(	(	PUNCT
ajlm-806	1	240	zambart	zambart	NOUN
ajlm-806	1	241	)	)	PUNCT
ajlm-806	1	242	project	project	NOUN
ajlm-806	1	243	,	,	PUNCT
ajlm-806	1	244	school	school	NOUN
ajlm-806	1	245	of	of	ADP
ajlm-806	1	246	medicine	medicine	NOUN
ajlm-806	1	247	,	,	PUNCT
ajlm-806	1	248	university	university	PROPN
ajlm-806	1	249	of	of	ADP
ajlm-806	1	250	zambia	zambia	PROPN
ajlm-806	1	251	,	,	PUNCT
ajlm-806	1	252	lusaka	lusaka	PROPN
ajlm-806	1	253	,	,	PUNCT
ajlm-806	1	254	zambia	zambia	PROPN
ajlm-806	1	255	citation	citation	PROPN
ajlm-806	1	256	mwanza	mwanza	PROPN
ajlm-806	1	257	w	w	PROPN
ajlm-806	1	258	,	,	PUNCT
ajlm-806	1	259	milimo	milimo	PROPN
ajlm-806	2	1	d	d	NOUN
ajlm-806	2	2	,	,	PUNCT
ajlm-806	2	3	chilufya	chilufya	PROPN
ajlm-806	2	4	mm	mm	PROPN
ajlm-806	2	5	,	,	PUNCT
ajlm-806	2	6	et	et	PROPN
ajlm-806	2	7	al	al	PROPN
ajlm-806	2	8	.	.	PUNCT
ajlm-806	2	9	diagnosis	diagnosis	NOUN
ajlm-806	2	10	of	of	ADP
ajlm-806	2	11	rifampicin	rifampicin	VERB
ajlm-806	2	12	-	-	PUNCT
ajlm-806	2	13	resistant	resistant	ADJ
ajlm-806	2	14	tuberculosis	tuberculosis	NOUN
ajlm-806	2	15	:	:	PUNCT
ajlm-806	2	16	discordant	discordant	ADJ
ajlm-806	2	17	results	result	NOUN
ajlm-806	2	18	by	by	ADP
ajlm-806	2	19	diagnostic	diagnostic	ADJ
ajlm-806	2	20	methods	method	NOUN
ajlm-806	2	21	.	.	PUNCT
ajlm-806	3	1	afr	afr	PROPN
ajlm-806	3	2	j	j	PROPN
ajlm-806	3	3	lab	lab	PROPN
ajlm-806	3	4	med	med	PROPN
ajlm-806	3	5	.	.	PUNCT
ajlm-806	3	6	2018;7(2	2018;7(2	NUM
ajlm-806	3	7	)	)	PUNCT
ajlm-806	3	8	,	,	PUNCT
ajlm-806	3	9	a806	a806	PROPN
ajlm-806	3	10	.	.	PUNCT
ajlm-806	4	1	https://doi.org/10.4102/ajlm.v7i2.806	https://doi.org/10.4102/ajlm.v7i2.806	PROPN
ajlm-806	4	2	brief	brief	ADJ
ajlm-806	4	3	report	report	NOUN
ajlm-806	4	4	diagnosis	diagnosis	NOUN
ajlm-806	4	5	of	of	ADP
ajlm-806	4	6	rifampicin	rifampicin	VERB
ajlm-806	4	7	-	-	PUNCT
ajlm-806	4	8	resistant	resistant	ADJ
ajlm-806	4	9	tuberculosis	tuberculosis	NOUN
ajlm-806	4	10	:	:	PUNCT
ajlm-806	4	11	discordant	discordant	ADJ
ajlm-806	4	12	results	result	NOUN
ajlm-806	4	13	by	by	ADP
ajlm-806	4	14	diagnostic	diagnostic	ADJ
ajlm-806	4	15	methods	method	NOUN
ajlm-806	4	16	winnie	winnie	PROPN
ajlm-806	4	17	mwanza	mwanza	PROPN
ajlm-806	4	18	,	,	PUNCT
ajlm-806	4	19	deborah	deborah	PROPN
ajlm-806	4	20	milimo	milimo	PROPN
ajlm-806	4	21	,	,	PUNCT
ajlm-806	4	22	maureen	maureen	PROPN
ajlm-806	4	23	m.	m.	PROPN
ajlm-806	4	24	chilufya	chilufya	PROPN
ajlm-806	4	25	,	,	PUNCT
ajlm-806	4	26	nkatya	nkatya	PROPN
ajlm-806	4	27	kasese	kasese	PROPN
ajlm-806	4	28	,	,	PUNCT
ajlm-806	4	29	maina	maina	PROPN
ajlm-806	4	30	c.	c.	PROPN
ajlm-806	4	31	lengwe	lengwe	PROPN
ajlm-806	4	32	,	,	PUNCT
ajlm-806	4	33	stembiso	stembiso	VERB
ajlm-806	4	34	munkondya	munkondya	PROPN
ajlm-806	4	35	,	,	PUNCT
ajlm-806	4	36	petra	petra	PROPN
ajlm-806	4	37	de	de	PROPN
ajlm-806	4	38	haas	haas	PROPN
ajlm-806	4	39	,	,	PUNCT
ajlm-806	4	40	helen	helen	PROPN
ajlm-806	4	41	ayles	ayle	NOUN
ajlm-806	4	42	,	,	PUNCT
ajlm-806	4	43	monde	monde	PROPN
ajlm-806	4	44	muyoyeta	muyoyeta	NOUN
ajlm-806	4	45	received	receive	VERB
ajlm-806	4	46	:	:	PUNCT
ajlm-806	4	47	09	09	NUM
ajlm-806	4	48	apr	apr	NOUN
ajlm-806	4	49	.	.	PROPN
ajlm-806	4	50	2018	2018	NUM
ajlm-806	4	51	;	;	PUNCT
ajlm-806	4	52	accepted	accept	VERB
ajlm-806	4	53	:	:	PUNCT
ajlm-806	4	54	26	26	NUM
ajlm-806	4	55	sept	sept	PROPN
ajlm-806	4	56	.	.	PROPN
ajlm-806	4	57	2018	2018	NUM
ajlm-806	4	58	;	;	PUNCT
ajlm-806	4	59	published	publish	VERB
ajlm-806	4	60	:	:	PUNCT
ajlm-806	4	61	06	06	NUM
ajlm-806	4	62	dec	dec	PROPN
ajlm-806	4	63	.	.	PROPN
ajlm-806	5	1	2018	2018	NUM
ajlm-806	5	2	copyright	copyright	NOUN
ajlm-806	5	3	:	:	PUNCT
ajlm-806	5	4	©	©	PROPN
ajlm-806	5	5	2018	2018	NUM
ajlm-806	5	6	.	.	PUNCT
ajlm-806	6	1	the	the	DET
ajlm-806	6	2	author(s	author(s	PROPN
ajlm-806	6	3	)	)	PUNCT
ajlm-806	6	4	.	.	PUNCT
ajlm-806	7	1	licensee	licensee	NOUN
ajlm-806	7	2	:	:	PUNCT
ajlm-806	7	3	aosis	aosis	NOUN
ajlm-806	7	4	.	.	PUNCT
ajlm-806	8	1	this	this	PRON
ajlm-806	8	2	is	be	AUX
ajlm-806	8	3	an	an	DET
ajlm-806	8	4	open	open	ADJ
ajlm-806	8	5	access	access	NOUN
ajlm-806	8	6	article	article	NOUN
ajlm-806	8	7	distributed	distribute	VERB
ajlm-806	8	8	under	under	ADP
ajlm-806	8	9	the	the	DET
ajlm-806	8	10	terms	term	NOUN
ajlm-806	8	11	of	of	ADP
ajlm-806	8	12	the	the	DET
ajlm-806	8	13	creative	creative	ADJ
ajlm-806	8	14	commons	common	NOUN
ajlm-806	8	15	attribution	attribution	NOUN
ajlm-806	8	16	license	license	NOUN
ajlm-806	8	17	,	,	PUNCT
ajlm-806	8	18	which	which	PRON
ajlm-806	8	19	permits	permit	VERB
ajlm-806	8	20	unrestricted	unrestricted	ADJ
ajlm-806	8	21	use	use	NOUN
ajlm-806	8	22	,	,	PUNCT
ajlm-806	8	23	distribution	distribution	NOUN
ajlm-806	8	24	,	,	PUNCT
ajlm-806	8	25	and	and	CCONJ
ajlm-806	8	26	reproduction	reproduction	NOUN
ajlm-806	8	27	in	in	ADP
ajlm-806	8	28	any	any	DET
ajlm-806	8	29	medium	medium	NOUN
ajlm-806	8	30	,	,	PUNCT
ajlm-806	8	31	provided	provide	VERB
ajlm-806	8	32	the	the	DET
ajlm-806	8	33	original	original	ADJ
ajlm-806	8	34	work	work	NOUN
ajlm-806	8	35	is	be	AUX
ajlm-806	8	36	properly	properly	ADV
ajlm-806	8	37	cited	cite	VERB
ajlm-806	8	38	.	.	PUNCT
ajlm-806	9	1	abstract	abstract	ADJ
ajlm-806	9	2	the	the	DET
ajlm-806	9	3	performance	performance	NOUN
ajlm-806	9	4	of	of	ADP
ajlm-806	9	5	the	the	DET
ajlm-806	9	6	xpert	xpert	PROPN
ajlm-806	9	7	©	©	PROPN
ajlm-806	9	8	mtb	mtb	PROPN
ajlm-806	9	9	/	/	SYM
ajlm-806	9	10	rif	rif	PROPN
ajlm-806	9	11	and	and	CCONJ
ajlm-806	9	12	mtbdrplus	mtbdrplus	ADJ
ajlm-806	9	13	assays	assay	NOUN
ajlm-806	9	14	for	for	ADP
ajlm-806	9	15	the	the	DET
ajlm-806	9	16	detection	detection	NOUN
ajlm-806	9	17	of	of	ADP
ajlm-806	9	18	rifampicin	rifampicin	VERB
ajlm-806	9	19	resistant	resistant	ADJ
ajlm-806	9	20	mycobacterium	mycobacterium	NOUN
ajlm-806	9	21	tuberculosis	tuberculosis	NOUN
ajlm-806	9	22	was	be	AUX
ajlm-806	9	23	compared	compare	VERB
ajlm-806	9	24	to	to	ADP
ajlm-806	9	25	culture	culture	NOUN
ajlm-806	9	26	-	-	PUNCT
ajlm-806	9	27	based	base	VERB
ajlm-806	9	28	drug	drug	NOUN
ajlm-806	9	29	susceptibility	susceptibility	NOUN
ajlm-806	9	30	testing	testing	NOUN
ajlm-806	9	31	in	in	ADP
ajlm-806	9	32	30	30	NUM
ajlm-806	9	33	specimens	specimen	NOUN
ajlm-806	9	34	with	with	ADP
ajlm-806	9	35	rifampicin	rifampicin	VERB
ajlm-806	9	36	-	-	PUNCT
ajlm-806	9	37	resistant	resistant	ADJ
ajlm-806	9	38	and	and	CCONJ
ajlm-806	9	39	rifampicin	rifampicin	NOUN
ajlm-806	9	40	-	-	PUNCT
ajlm-806	9	41	indeterminate	indeterminate	NOUN
ajlm-806	9	42	xpert	xpert	PROPN
ajlm-806	9	43	mtb	mtb	PROPN
ajlm-806	9	44	/	/	SYM
ajlm-806	9	45	rif	rif	PROPN
ajlm-806	9	46	results	result	NOUN
ajlm-806	9	47	collected	collect	VERB
ajlm-806	9	48	between	between	ADP
ajlm-806	9	49	march	march	PROPN
ajlm-806	9	50	2012	2012	NUM
ajlm-806	9	51	and	and	CCONJ
ajlm-806	9	52	march	march	PROPN
ajlm-806	9	53	2014	2014	NUM
ajlm-806	9	54	.	.	PUNCT
ajlm-806	10	1	xpert	xpert	PROPN
ajlm-806	10	2	mtb	mtb	PROPN
ajlm-806	10	3	/	/	SYM
ajlm-806	10	4	rif	rif	PROPN
ajlm-806	10	5	and	and	CCONJ
ajlm-806	10	6	mtbdrplus	mtbdrplus	ADJ
ajlm-806	10	7	were	be	AUX
ajlm-806	10	8	100	100	NUM
ajlm-806	10	9	%	%	NOUN
ajlm-806	10	10	sensitive	sensitive	ADJ
ajlm-806	10	11	and	and	CCONJ
ajlm-806	10	12	100	100	NUM
ajlm-806	10	13	%	%	NOUN
ajlm-806	10	14	concordant	concordant	ADJ
ajlm-806	10	15	for	for	ADP
ajlm-806	10	16	rifampicin	rifampicin	VERB
ajlm-806	10	17	resistance	resistance	NOUN
ajlm-806	10	18	detection	detection	NOUN
ajlm-806	10	19	,	,	PUNCT
ajlm-806	10	20	but	but	CCONJ
ajlm-806	10	21	3	3	NUM
ajlm-806	10	22	of	of	ADP
ajlm-806	10	23	13	13	NUM
ajlm-806	10	24	samples	sample	NOUN
ajlm-806	10	25	(	(	PUNCT
ajlm-806	10	26	23	23	NUM
ajlm-806	10	27	%	%	NOUN
ajlm-806	10	28	)	)	PUNCT
ajlm-806	10	29	positive	positive	ADJ
ajlm-806	10	30	for	for	ADP
ajlm-806	10	31	rifampicin	rifampicin	VERB
ajlm-806	10	32	resistance	resistance	NOUN
ajlm-806	10	33	on	on	ADP
ajlm-806	10	34	xpert	xpert	PROPN
ajlm-806	10	35	mtb	mtb	PROPN
ajlm-806	10	36	/	/	SYM
ajlm-806	10	37	rif	rif	PROPN
ajlm-806	10	38	and	and	CCONJ
ajlm-806	10	39	mtbdrplus	mtbdrplus	ADJ
ajlm-806	10	40	were	be	AUX
ajlm-806	10	41	negative	negative	ADJ
ajlm-806	10	42	for	for	ADP
ajlm-806	10	43	rifampicin	rifampicin	VERB
ajlm-806	10	44	resistance	resistance	NOUN
ajlm-806	10	45	on	on	ADP
ajlm-806	10	46	mycobacteria	mycobacteria	NOUN
ajlm-806	10	47	growth	growth	NOUN
ajlm-806	10	48	indicator	indicator	NOUN
ajlm-806	10	49	tube	tube	NOUN
ajlm-806	10	50	drug	drug	NOUN
ajlm-806	10	51	susceptibility	susceptibility	NOUN
ajlm-806	10	52	testing	testing	NOUN
ajlm-806	10	53	.	.	PUNCT
ajlm-806	11	1	specificity	specificity	NOUN
ajlm-806	11	2	was	be	AUX
ajlm-806	11	3	72	72	NUM
ajlm-806	11	4	%	%	NOUN
ajlm-806	11	5	for	for	ADP
ajlm-806	11	6	xpert	xpert	PROPN
ajlm-806	11	7	mtb	mtb	PROPN
ajlm-806	11	8	/	/	SYM
ajlm-806	11	9	rif	rif	PROPN
ajlm-806	11	10	and	and	CCONJ
ajlm-806	11	11	80	80	NUM
ajlm-806	11	12	%	%	NOUN
ajlm-806	11	13	for	for	ADP
ajlm-806	11	14	mtbdrplus	mtbdrplus	ADJ
ajlm-806	11	15	.	.	PUNCT
ajlm-806	12	1	positive	positive	ADJ
ajlm-806	12	2	predictive	predictive	ADJ
ajlm-806	12	3	value	value	NOUN
ajlm-806	12	4	for	for	ADP
ajlm-806	12	5	xpert	xpert	PROPN
ajlm-806	12	6	mtb	mtb	PROPN
ajlm-806	12	7	/	/	SYM
ajlm-806	12	8	rif	rif	PROPN
ajlm-806	12	9	for	for	ADP
ajlm-806	12	10	multidrug	multidrug	NOUN
ajlm-806	12	11	resistant	resistant	ADJ
ajlm-806	12	12	tuberculosis	tuberculosis	NOUN
ajlm-806	12	13	was	be	AUX
ajlm-806	12	14	47.8	47.8	NUM
ajlm-806	12	15	%	%	NOUN
ajlm-806	12	16	for	for	ADP
ajlm-806	12	17	new	new	ADJ
ajlm-806	12	18	patients	patient	NOUN
ajlm-806	12	19	and	and	CCONJ
ajlm-806	12	20	77.8	77.8	NUM
ajlm-806	12	21	%	%	NOUN
ajlm-806	12	22	for	for	ADP
ajlm-806	12	23	previously	previously	ADV
ajlm-806	12	24	treated	treat	VERB
ajlm-806	12	25	patients	patient	NOUN
ajlm-806	12	26	;	;	PUNCT
ajlm-806	12	27	negative	negative	ADJ
ajlm-806	12	28	predictive	predictive	ADJ
ajlm-806	12	29	value	value	NOUN
ajlm-806	12	30	was	be	AUX
ajlm-806	12	31	100	100	NUM
ajlm-806	12	32	%	%	NOUN
ajlm-806	12	33	for	for	ADP
ajlm-806	12	34	both	both	CCONJ
ajlm-806	12	35	new	new	ADJ
ajlm-806	12	36	and	and	CCONJ
ajlm-806	12	37	previously	previously	ADV
ajlm-806	12	38	treated	treat	VERB
ajlm-806	12	39	patients	patient	NOUN
ajlm-806	12	40	.	.	PUNCT
ajlm-806	13	1	the	the	DET
ajlm-806	13	2	discordant	discordant	ADJ
ajlm-806	13	3	rifampicin	rifampicin	VERB
ajlm-806	13	4	resistance	resistance	NOUN
ajlm-806	13	5	test	test	NOUN
ajlm-806	13	6	results	result	NOUN
ajlm-806	13	7	indicate	indicate	VERB
ajlm-806	13	8	a	a	DET
ajlm-806	13	9	need	need	NOUN
ajlm-806	13	10	to	to	PART
ajlm-806	13	11	fully	fully	ADV
ajlm-806	13	12	characterise	characterise	VERB
ajlm-806	13	13	circulating	circulate	VERB
ajlm-806	13	14	rifampicin	rifampicin	VERB
ajlm-806	13	15	resistant	resistant	ADJ
ajlm-806	13	16	mycobacterium	mycobacterium	NOUN
ajlm-806	13	17	tuberculosis	tuberculosis	NOUN
ajlm-806	13	18	strains	strain	NOUN
ajlm-806	13	19	in	in	ADP
ajlm-806	13	20	zambia	zambia	PROPN
ajlm-806	13	21	and	and	CCONJ
ajlm-806	13	22	to	to	PART
ajlm-806	13	23	inform	inform	VERB
ajlm-806	13	24	the	the	DET
ajlm-806	13	25	development	development	NOUN
ajlm-806	13	26	of	of	ADP
ajlm-806	13	27	guidelines	guideline	NOUN
ajlm-806	13	28	for	for	ADP
ajlm-806	13	29	decision	decision	NOUN
ajlm-806	13	30	-	-	PUNCT
ajlm-806	13	31	making	making	NOUN
ajlm-806	13	32	in	in	ADP
ajlm-806	13	33	relation	relation	NOUN
ajlm-806	13	34	to	to	ADP
ajlm-806	13	35	diagnosis	diagnosis	NOUN
ajlm-806	13	36	of	of	ADP
ajlm-806	13	37	drug	drug	NOUN
ajlm-806	13	38	-	-	PUNCT
ajlm-806	13	39	resistant	resistant	ADJ
ajlm-806	13	40	tuberculosis	tuberculosis	NOUN
ajlm-806	13	41	.	.	PUNCT
ajlm-806	14	1	introduction	introduction	NOUN
ajlm-806	14	2	management	management	NOUN
ajlm-806	14	3	and	and	CCONJ
ajlm-806	14	4	control	control	NOUN
ajlm-806	14	5	of	of	ADP
ajlm-806	14	6	multidrug	multidrug	NOUN
ajlm-806	14	7	resistant	resistant	ADJ
ajlm-806	14	8	(	(	PUNCT
ajlm-806	14	9	mdr	mdr	NOUN
ajlm-806	14	10	)	)	PUNCT
ajlm-806	14	11	tuberculosis	tuberculosis	NOUN
ajlm-806	14	12	,	,	PUNCT
ajlm-806	14	13	tuberculosis	tuberculosis	NOUN
ajlm-806	14	14	that	that	PRON
ajlm-806	14	15	is	be	AUX
ajlm-806	14	16	resistant	resistant	ADJ
ajlm-806	14	17	to	to	ADP
ajlm-806	14	18	both	both	DET
ajlm-806	14	19	isoniazid	isoniazid	NOUN
ajlm-806	14	20	and	and	CCONJ
ajlm-806	14	21	rifampicin	rifampicin	VERB
ajlm-806	14	22	,	,	PUNCT
ajlm-806	14	23	relies	rely	VERB
ajlm-806	14	24	on	on	ADP
ajlm-806	14	25	timely	timely	ADJ
ajlm-806	14	26	and	and	CCONJ
ajlm-806	14	27	correct	correct	ADJ
ajlm-806	14	28	diagnosis	diagnosis	NOUN
ajlm-806	14	29	.	.	PUNCT
ajlm-806	15	1	the	the	DET
ajlm-806	15	2	world	world	PROPN
ajlm-806	15	3	health	health	PROPN
ajlm-806	15	4	organization	organization	NOUN
ajlm-806	15	5	has	have	AUX
ajlm-806	15	6	endorsed	endorse	VERB
ajlm-806	15	7	the	the	DET
ajlm-806	15	8	xpert	xpert	PROPN
ajlm-806	15	9	®	®	PROPN
ajlm-806	15	10	mtb	mtb	PROPN
ajlm-806	15	11	/	/	SYM
ajlm-806	15	12	rif	rif	PROPN
ajlm-806	15	13	(	(	PUNCT
ajlm-806	15	14	cepheid	cepheid	PROPN
ajlm-806	15	15	sunnyvale	sunnyvale	PROPN
ajlm-806	15	16	,	,	PUNCT
ajlm-806	15	17	ca	ca	PROPN
ajlm-806	15	18	,	,	PUNCT
ajlm-806	15	19	united	united	PROPN
ajlm-806	15	20	states	states	PROPN
ajlm-806	15	21	)	)	PUNCT
ajlm-806	15	22	and	and	CCONJ
ajlm-806	15	23	genotype	genotype	NOUN
ajlm-806	15	24	mtbdrplus	mtbdrplus	NOUN
ajlm-806	15	25	(	(	PUNCT
ajlm-806	15	26	hain	hain	PROPN
ajlm-806	15	27	life	life	NOUN
ajlm-806	15	28	sciences	science	NOUN
ajlm-806	15	29	,	,	PUNCT
ajlm-806	15	30	nehren	nehren	NOUN
ajlm-806	15	31	,	,	PUNCT
ajlm-806	15	32	germany	germany	PROPN
ajlm-806	15	33	)	)	PUNCT
ajlm-806	15	34	tests	test	VERB
ajlm-806	15	35	for	for	ADP
ajlm-806	15	36	rapid	rapid	ADJ
ajlm-806	15	37	diagnosis	diagnosis	NOUN
ajlm-806	15	38	of	of	ADP
ajlm-806	15	39	mdr	mdr	PROPN
ajlm-806	15	40	tuberculosis.1,2	tuberculosis.1,2	PROPN
ajlm-806	15	41	for	for	ADP
ajlm-806	15	42	the	the	DET
ajlm-806	15	43	xpert	xpert	PROPN
ajlm-806	15	44	mtb	mtb	PROPN
ajlm-806	15	45	/	/	SYM
ajlm-806	15	46	rif	rif	PROPN
ajlm-806	15	47	test	test	NOUN
ajlm-806	15	48	,	,	PUNCT
ajlm-806	15	49	the	the	DET
ajlm-806	15	50	current	current	ADJ
ajlm-806	15	51	recommendation	recommendation	NOUN
ajlm-806	15	52	is	be	AUX
ajlm-806	15	53	to	to	PART
ajlm-806	15	54	treat	treat	VERB
ajlm-806	15	55	any	any	DET
ajlm-806	15	56	rifampicin	rifampicin	VERB
ajlm-806	15	57	-	-	PUNCT
ajlm-806	15	58	resistant	resistant	ADJ
ajlm-806	15	59	individual	individual	NOUN
ajlm-806	15	60	as	as	ADP
ajlm-806	15	61	a	a	DET
ajlm-806	15	62	case	case	NOUN
ajlm-806	15	63	of	of	ADP
ajlm-806	15	64	mdr	mdr	PROPN
ajlm-806	15	65	tuberculosis	tuberculosis	NOUN
ajlm-806	15	66	until	until	SCONJ
ajlm-806	15	67	proven	prove	VERB
ajlm-806	15	68	otherwise	otherwise	ADV
ajlm-806	15	69	by	by	ADP
ajlm-806	15	70	subsequent	subsequent	ADJ
ajlm-806	15	71	drug	drug	NOUN
ajlm-806	15	72	susceptibility	susceptibility	NOUN
ajlm-806	15	73	testing	testing	NOUN
ajlm-806	15	74	,	,	PUNCT
ajlm-806	15	75	after	after	SCONJ
ajlm-806	15	76	which	which	DET
ajlm-806	15	77	treatment	treatment	NOUN
ajlm-806	15	78	is	be	AUX
ajlm-806	15	79	to	to	PART
ajlm-806	15	80	be	be	AUX
ajlm-806	15	81	tailored	tailor	VERB
ajlm-806	15	82	or	or	CCONJ
ajlm-806	15	83	individualised	individualise	VERB
ajlm-806	15	84	accordingly	accordingly	ADV
ajlm-806	15	85	.	.	PUNCT
ajlm-806	16	1	the	the	DET
ajlm-806	16	2	combination	combination	NOUN
ajlm-806	16	3	of	of	ADP
ajlm-806	16	4	xpert	xpert	PROPN
ajlm-806	16	5	mtb	mtb	PROPN
ajlm-806	16	6	/	/	SYM
ajlm-806	16	7	rif	rif	PROPN
ajlm-806	16	8	and	and	CCONJ
ajlm-806	16	9	mtbdrplus	mtbdrplus	ADJ
ajlm-806	16	10	test	test	NOUN
ajlm-806	16	11	results	result	NOUN
ajlm-806	16	12	would	would	AUX
ajlm-806	16	13	be	be	AUX
ajlm-806	16	14	a	a	DET
ajlm-806	16	15	powerful	powerful	ADJ
ajlm-806	16	16	tool	tool	NOUN
ajlm-806	16	17	to	to	PART
ajlm-806	16	18	achieve	achieve	VERB
ajlm-806	16	19	prompt	prompt	ADJ
ajlm-806	16	20	confirmation	confirmation	NOUN
ajlm-806	16	21	of	of	ADP
ajlm-806	16	22	diagnosis	diagnosis	NOUN
ajlm-806	16	23	of	of	ADP
ajlm-806	16	24	mdr	mdr	PROPN
ajlm-806	16	25	tuberculosis	tuberculosis	NOUN
ajlm-806	16	26	.	.	PUNCT
ajlm-806	17	1	these	these	DET
ajlm-806	17	2	genotypic	genotypic	ADJ
ajlm-806	17	3	methods	method	NOUN
ajlm-806	17	4	,	,	PUNCT
ajlm-806	17	5	however	however	ADV
ajlm-806	17	6	,	,	PUNCT
ajlm-806	17	7	do	do	AUX
ajlm-806	17	8	not	not	PART
ajlm-806	17	9	detect	detect	VERB
ajlm-806	17	10	resistance	resistance	NOUN
ajlm-806	17	11	conferred	confer	VERB
ajlm-806	17	12	by	by	ADP
ajlm-806	17	13	mutations	mutation	NOUN
ajlm-806	17	14	outside	outside	ADP
ajlm-806	17	15	of	of	ADP
ajlm-806	17	16	the	the	DET
ajlm-806	17	17	targeted	target	VERB
ajlm-806	17	18	gene	gene	NOUN
ajlm-806	17	19	region.3,4,5	region.3,4,5	NOUN
ajlm-806	17	20	we	we	PRON
ajlm-806	17	21	report	report	VERB
ajlm-806	17	22	comparative	comparative	ADJ
ajlm-806	17	23	observations	observation	NOUN
ajlm-806	17	24	made	make	VERB
ajlm-806	17	25	in	in	ADP
ajlm-806	17	26	a	a	DET
ajlm-806	17	27	pilot	pilot	NOUN
ajlm-806	17	28	study	study	NOUN
ajlm-806	17	29	on	on	ADP
ajlm-806	17	30	the	the	DET
ajlm-806	17	31	performance	performance	NOUN
ajlm-806	17	32	of	of	ADP
ajlm-806	17	33	xpert	xpert	PROPN
ajlm-806	17	34	mtb	mtb	PROPN
ajlm-806	17	35	/	/	SYM
ajlm-806	17	36	rif	rif	PROPN
ajlm-806	17	37	,	,	PUNCT
ajlm-806	17	38	mtbdrplus	mtbdrplus	ADJ
ajlm-806	17	39	and	and	CCONJ
ajlm-806	17	40	mycobacteria	mycobacteria	NOUN
ajlm-806	17	41	growth	growth	NOUN
ajlm-806	17	42	indicator	indicator	NOUN
ajlm-806	17	43	tube	tube	NOUN
ajlm-806	17	44	(	(	PUNCT
ajlm-806	17	45	mgit	mgit	ADJ
ajlm-806	17	46	)	)	PUNCT
ajlm-806	17	47	drug	drug	NOUN
ajlm-806	17	48	susceptibility	susceptibility	NOUN
ajlm-806	17	49	testing	testing	NOUN
ajlm-806	17	50	methods	method	NOUN
ajlm-806	17	51	for	for	ADP
ajlm-806	17	52	detection	detection	NOUN
ajlm-806	17	53	of	of	ADP
ajlm-806	17	54	rifampicin	rifampicin	VERB
ajlm-806	17	55	resistance	resistance	NOUN
ajlm-806	17	56	in	in	ADP
ajlm-806	17	57	lusaka	lusaka	PROPN
ajlm-806	17	58	,	,	PUNCT
ajlm-806	17	59	zambia	zambia	PROPN
ajlm-806	17	60	,	,	PUNCT
ajlm-806	17	61	at	at	ADP
ajlm-806	17	62	the	the	DET
ajlm-806	17	63	zambart	zambart	NOUN
ajlm-806	17	64	central	central	PROPN
ajlm-806	17	65	laboratory	laboratory	NOUN
ajlm-806	17	66	(	(	PUNCT
ajlm-806	17	67	zcl	zcl	NOUN
ajlm-806	17	68	)	)	PUNCT
ajlm-806	17	69	.	.	PUNCT
ajlm-806	18	1	methods	method	NOUN
ajlm-806	18	2	ethical	ethical	ADJ
ajlm-806	18	3	considerations	consideration	NOUN
ajlm-806	18	4	the	the	DET
ajlm-806	18	5	study	study	NOUN
ajlm-806	18	6	was	be	AUX
ajlm-806	18	7	approved	approve	VERB
ajlm-806	18	8	by	by	ADP
ajlm-806	18	9	the	the	DET
ajlm-806	18	10	university	university	PROPN
ajlm-806	18	11	of	of	ADP
ajlm-806	18	12	zambia	zambia	PROPN
ajlm-806	18	13	biomedical	biomedical	PROPN
ajlm-806	18	14	research	research	PROPN
ajlm-806	18	15	ethics	ethic	NOUN
ajlm-806	18	16	committee	committee	PROPN
ajlm-806	18	17	(	(	PUNCT
ajlm-806	18	18	ref	ref	NOUN
ajlm-806	18	19	.	.	PUNCT
ajlm-806	19	1	no	no	INTJ
ajlm-806	19	2	.	.	NOUN
ajlm-806	19	3	003	003	NUM
ajlm-806	19	4	-	-	SYM
ajlm-806	19	5	12	12	NUM
ajlm-806	19	6	-	-	PUNCT
ajlm-806	19	7	11	11	NUM
ajlm-806	19	8	)	)	PUNCT
ajlm-806	19	9	and	and	CCONJ
ajlm-806	19	10	all	all	DET
ajlm-806	19	11	patients	patient	NOUN
ajlm-806	19	12	were	be	AUX
ajlm-806	19	13	requested	request	VERB
ajlm-806	19	14	to	to	PART
ajlm-806	19	15	give	give	VERB
ajlm-806	19	16	written	write	VERB
ajlm-806	19	17	informed	informed	ADJ
ajlm-806	19	18	consent	consent	NOUN
ajlm-806	19	19	before	before	ADP
ajlm-806	19	20	participating	participate	VERB
ajlm-806	19	21	in	in	ADP
ajlm-806	19	22	the	the	DET
ajlm-806	19	23	study	study	NOUN
ajlm-806	19	24	.	.	PUNCT
ajlm-806	20	1	the	the	DET
ajlm-806	20	2	written	write	VERB
ajlm-806	20	3	informed	inform	VERB
ajlm-806	20	4	consent	consent	NOUN
ajlm-806	20	5	was	be	AUX
ajlm-806	20	6	administered	administer	VERB
ajlm-806	20	7	by	by	ADP
ajlm-806	20	8	study	study	NOUN
ajlm-806	20	9	staff	staff	NOUN
ajlm-806	20	10	,	,	PUNCT
ajlm-806	20	11	and	and	CCONJ
ajlm-806	20	12	participants	participant	NOUN
ajlm-806	20	13	were	be	AUX
ajlm-806	20	14	given	give	VERB
ajlm-806	20	15	an	an	DET
ajlm-806	20	16	opportunity	opportunity	NOUN
ajlm-806	20	17	to	to	PART
ajlm-806	20	18	discuss	discuss	VERB
ajlm-806	20	19	the	the	DET
ajlm-806	20	20	study	study	NOUN
ajlm-806	20	21	before	before	ADP
ajlm-806	20	22	signing	sign	VERB
ajlm-806	20	23	the	the	DET
ajlm-806	20	24	informed	informed	ADJ
ajlm-806	20	25	consent	consent	NOUN
ajlm-806	20	26	form	form	NOUN
ajlm-806	20	27	.	.	PUNCT
ajlm-806	21	1	to	to	PART
ajlm-806	21	2	maintain	maintain	VERB
ajlm-806	21	3	confidentiality	confidentiality	NOUN
ajlm-806	21	4	,	,	PUNCT
ajlm-806	21	5	each	each	DET
ajlm-806	21	6	participant	participant	NOUN
ajlm-806	21	7	was	be	AUX
ajlm-806	21	8	allocated	allocate	VERB
ajlm-806	21	9	a	a	DET
ajlm-806	21	10	unique	unique	ADJ
ajlm-806	21	11	study	study	NOUN
ajlm-806	21	12	number	number	NOUN
ajlm-806	21	13	that	that	PRON
ajlm-806	21	14	was	be	AUX
ajlm-806	21	15	used	use	VERB
ajlm-806	21	16	on	on	ADP
ajlm-806	21	17	all	all	DET
ajlm-806	21	18	data	datum	NOUN
ajlm-806	21	19	collection	collection	NOUN
ajlm-806	21	20	tools	tool	NOUN
ajlm-806	21	21	,	,	PUNCT
ajlm-806	21	22	as	as	ADV
ajlm-806	21	23	well	well	ADV
ajlm-806	21	24	as	as	ADP
ajlm-806	21	25	for	for	ADP
ajlm-806	21	26	labelling	labelling	NOUN
ajlm-806	21	27	of	of	ADP
ajlm-806	21	28	laboratory	laboratory	NOUN
ajlm-806	21	29	specimens	specimen	NOUN
ajlm-806	21	30	.	.	PUNCT
ajlm-806	22	1	no	no	DET
ajlm-806	22	2	names	name	NOUN
ajlm-806	22	3	were	be	AUX
ajlm-806	22	4	used	use	VERB
ajlm-806	22	5	on	on	ADP
ajlm-806	22	6	any	any	DET
ajlm-806	22	7	data	data	NOUN
ajlm-806	22	8	collection	collection	NOUN
ajlm-806	22	9	tool	tool	NOUN
ajlm-806	22	10	.	.	PUNCT
ajlm-806	23	1	informed	inform	VERB
ajlm-806	23	2	consent	consent	NOUN
ajlm-806	23	3	forms	form	NOUN
ajlm-806	23	4	and	and	CCONJ
ajlm-806	23	5	all	all	DET
ajlm-806	23	6	study	study	NOUN
ajlm-806	23	7	data	datum	NOUN
ajlm-806	23	8	were	be	AUX
ajlm-806	23	9	kept	keep	VERB
ajlm-806	23	10	in	in	ADP
ajlm-806	23	11	secure	secure	ADJ
ajlm-806	23	12	cabinets	cabinet	NOUN
ajlm-806	23	13	with	with	ADP
ajlm-806	23	14	access	access	NOUN
ajlm-806	23	15	limited	limit	VERB
ajlm-806	23	16	to	to	ADP
ajlm-806	23	17	the	the	DET
ajlm-806	23	18	principal	principal	ADJ
ajlm-806	23	19	investigator	investigator	NOUN
ajlm-806	23	20	and	and	CCONJ
ajlm-806	23	21	the	the	DET
ajlm-806	23	22	data	data	NOUN
ajlm-806	23	23	manager	manager	NOUN
ajlm-806	23	24	.	.	PUNCT
ajlm-806	24	1	paper	paper	NOUN
ajlm-806	24	2	-	-	PUNCT
ajlm-806	24	3	based	base	VERB
ajlm-806	24	4	case	case	NOUN
ajlm-806	24	5	report	report	NOUN
ajlm-806	24	6	forms	form	NOUN
ajlm-806	24	7	were	be	AUX
ajlm-806	24	8	captured	capture	VERB
ajlm-806	24	9	into	into	ADP
ajlm-806	24	10	secured	secure	VERB
ajlm-806	24	11	,	,	PUNCT
ajlm-806	24	12	password	password	NOUN
ajlm-806	24	13	-	-	PUNCT
ajlm-806	24	14	protected	protect	VERB
ajlm-806	24	15	electronic	electronic	ADJ
ajlm-806	24	16	databases	database	NOUN
ajlm-806	24	17	.	.	PUNCT
ajlm-806	25	1	study	study	NOUN
ajlm-806	25	2	design	design	VERB
ajlm-806	25	3	the	the	DET
ajlm-806	25	4	study	study	NOUN
ajlm-806	25	5	was	be	AUX
ajlm-806	25	6	conducted	conduct	VERB
ajlm-806	25	7	between	between	ADP
ajlm-806	25	8	march	march	PROPN
ajlm-806	25	9	2012	2012	NUM
ajlm-806	25	10	and	and	CCONJ
ajlm-806	25	11	march	march	PROPN
ajlm-806	25	12	2014	2014	NUM
ajlm-806	25	13	on	on	ADP
ajlm-806	25	14	samples	sample	NOUN
ajlm-806	25	15	collected	collect	VERB
ajlm-806	25	16	during	during	ADP
ajlm-806	25	17	an	an	DET
ajlm-806	25	18	evaluation	evaluation	NOUN
ajlm-806	25	19	of	of	ADP
ajlm-806	25	20	xpert	xpert	PROPN
ajlm-806	25	21	mtb	mtb	PROPN
ajlm-806	25	22	/	/	SYM
ajlm-806	25	23	rif	rif	PROPN
ajlm-806	25	24	use	use	NOUN
ajlm-806	25	25	in	in	ADP
ajlm-806	25	26	primary	primary	ADJ
ajlm-806	25	27	health	health	NOUN
ajlm-806	25	28	care	care	NOUN
ajlm-806	25	29	facilities	facility	NOUN
ajlm-806	25	30	in	in	ADP
ajlm-806	25	31	lusaka	lusaka	PROPN
ajlm-806	25	32	,	,	PUNCT
ajlm-806	25	33	zambia.6,7	zambia.6,7	NOUN
ajlm-806	25	34	samples	sample	NOUN
ajlm-806	25	35	were	be	AUX
ajlm-806	25	36	collected	collect	VERB
ajlm-806	25	37	from	from	ADP
ajlm-806	25	38	consecutive	consecutive	ADJ
ajlm-806	25	39	patients	patient	NOUN
ajlm-806	25	40	presenting	present	VERB
ajlm-806	25	41	to	to	ADP
ajlm-806	25	42	the	the	DET
ajlm-806	25	43	primary	primary	ADJ
ajlm-806	25	44	health	health	NOUN
ajlm-806	25	45	care	care	NOUN
ajlm-806	25	46	facility	facility	NOUN
ajlm-806	25	47	who	who	PRON
ajlm-806	25	48	had	have	VERB
ajlm-806	25	49	rifampicin	rifampicin	VERB
ajlm-806	25	50	-	-	PUNCT
ajlm-806	25	51	resistant	resistant	ADJ
ajlm-806	25	52	and	and	CCONJ
ajlm-806	25	53	rifampicin	rifampicin	NOUN
ajlm-806	25	54	-	-	PUNCT
ajlm-806	25	55	indeterminate	indeterminate	NOUN
ajlm-806	25	56	xpert	xpert	PROPN
ajlm-806	25	57	mtb	mtb	PROPN
ajlm-806	25	58	/	/	SYM
ajlm-806	25	59	rif	rif	PROPN
ajlm-806	25	60	results	result	NOUN
ajlm-806	25	61	for	for	ADP
ajlm-806	25	62	confirmation	confirmation	NOUN
ajlm-806	25	63	of	of	ADP
ajlm-806	25	64	rifampicin	rifampicin	VERB
ajlm-806	25	65	resistance	resistance	NOUN
ajlm-806	25	66	and	and	CCONJ
ajlm-806	25	67	for	for	ADP
ajlm-806	25	68	quality	quality	NOUN
ajlm-806	25	69	assurance	assurance	NOUN
ajlm-806	25	70	in	in	ADP
ajlm-806	25	71	the	the	DET
ajlm-806	25	72	zcl	zcl	PROPN
ajlm-806	25	73	.	.	PUNCT
ajlm-806	26	1	samples	sample	NOUN
ajlm-806	26	2	were	be	AUX
ajlm-806	26	3	transported	transport	VERB
ajlm-806	26	4	to	to	ADP
ajlm-806	26	5	the	the	DET
ajlm-806	26	6	central	central	ADJ
ajlm-806	26	7	laboratory	laboratory	NOUN
ajlm-806	26	8	on	on	ADP
ajlm-806	26	9	the	the	DET
ajlm-806	26	10	same	same	ADJ
ajlm-806	26	11	day	day	NOUN
ajlm-806	26	12	of	of	ADP
ajlm-806	26	13	collection	collection	NOUN
ajlm-806	26	14	or	or	CCONJ
ajlm-806	26	15	the	the	DET
ajlm-806	26	16	following	following	ADJ
ajlm-806	26	17	day	day	NOUN
ajlm-806	26	18	and	and	CCONJ
ajlm-806	26	19	no	no	DET
ajlm-806	26	20	preservatives	preservative	NOUN
ajlm-806	26	21	were	be	AUX
ajlm-806	26	22	added	add	VERB
ajlm-806	26	23	.	.	PUNCT
ajlm-806	27	1	at	at	ADP
ajlm-806	27	2	the	the	DET
ajlm-806	27	3	zcl	zcl	PROPN
ajlm-806	27	4	,	,	PUNCT
ajlm-806	27	5	the	the	DET
ajlm-806	27	6	samples	sample	NOUN
ajlm-806	27	7	were	be	AUX
ajlm-806	27	8	decontaminated	decontaminate	VERB
ajlm-806	27	9	using	use	VERB
ajlm-806	27	10	the	the	DET
ajlm-806	27	11	naoh	naoh	NOUN
ajlm-806	27	12	/	/	SYM
ajlm-806	27	13	nalc	nalc	PROPN
ajlm-806	27	14	method	method	NOUN
ajlm-806	27	15	(	(	PUNCT
ajlm-806	27	16	2	2	NUM
ajlm-806	27	17	%	%	NOUN
ajlm-806	27	18	naoh	naoh	NOUN
ajlm-806	27	19	for	for	ADP
ajlm-806	27	20	20	20	NUM
ajlm-806	27	21	minutes	minute	NOUN
ajlm-806	27	22	)	)	PUNCT
ajlm-806	27	23	and	and	CCONJ
ajlm-806	27	24	0.5	0.5	NUM
ajlm-806	27	25	ml	ml	NOUN
ajlm-806	27	26	of	of	ADP
ajlm-806	27	27	the	the	DET
ajlm-806	27	28	pellet	pellet	NOUN
ajlm-806	27	29	was	be	AUX
ajlm-806	27	30	inoculated	inoculate	VERB
ajlm-806	27	31	into	into	ADP
ajlm-806	27	32	each	each	PRON
ajlm-806	27	33	of	of	ADP
ajlm-806	27	34	two	two	NUM
ajlm-806	27	35	manual	manual	ADJ
ajlm-806	27	36	mgit	mgit	ADJ
ajlm-806	27	37	tubes	tube	NOUN
ajlm-806	27	38	for	for	ADP
ajlm-806	27	39	primary	primary	ADJ
ajlm-806	27	40	isolation	isolation	NOUN
ajlm-806	27	41	and	and	CCONJ
ajlm-806	27	42	identification	identification	NOUN
ajlm-806	27	43	of	of	ADP
ajlm-806	27	44	m.	m.	NOUN
ajlm-806	27	45	tuberculosis	tuberculosis	NOUN
ajlm-806	27	46	.	.	PUNCT
ajlm-806	27	47	;	;	PUNCT
ajlm-806	27	48	0.5	0.5	NUM
ajlm-806	27	49	ml	ml	NOUN
ajlm-806	27	50	was	be	AUX
ajlm-806	27	51	used	use	VERB
ajlm-806	27	52	to	to	PART
ajlm-806	27	53	repeat	repeat	VERB
ajlm-806	27	54	the	the	DET
ajlm-806	27	55	xpert	xpert	PROPN
ajlm-806	27	56	mtb	mtb	PROPN
ajlm-806	27	57	/	/	SYM
ajlm-806	27	58	rif	rif	PROPN
ajlm-806	27	59	test	test	NOUN
ajlm-806	27	60	,	,	PUNCT
ajlm-806	27	61	and	and	CCONJ
ajlm-806	27	62	two	two	NUM
ajlm-806	27	63	drops	drop	NOUN
ajlm-806	27	64	were	be	AUX
ajlm-806	27	65	used	use	VERB
ajlm-806	27	66	to	to	PART
ajlm-806	27	67	prepare	prepare	VERB
ajlm-806	27	68	a	a	DET
ajlm-806	27	69	concentrated	concentrated	ADJ
ajlm-806	27	70	smear	smear	NOUN
ajlm-806	27	71	for	for	ADP
ajlm-806	27	72	fluorescent	fluorescent	ADJ
ajlm-806	27	73	microscopy	microscopy	NOUN
ajlm-806	27	74	.	.	PUNCT
ajlm-806	28	1	1.5	1.5	NUM
ajlm-806	28	2	ml	ml	NOUN
ajlm-806	28	3	of	of	ADP
ajlm-806	28	4	the	the	DET
ajlm-806	28	5	xpert	xpert	PROPN
ajlm-806	28	6	mtb	mtb	PROPN
ajlm-806	28	7	/	/	SYM
ajlm-806	28	8	rif	rif	PROPN
ajlm-806	28	9	sample	sample	PROPN
ajlm-806	28	10	reagent	reagent	NOUN
ajlm-806	28	11	was	be	AUX
ajlm-806	28	12	added	add	VERB
ajlm-806	28	13	to	to	ADP
ajlm-806	28	14	0.5	0.5	NUM
ajlm-806	28	15	ml	ml	NOUN
ajlm-806	28	16	of	of	ADP
ajlm-806	28	17	the	the	DET
ajlm-806	28	18	re	re	ADJ
ajlm-806	28	19	-	-	VERB
ajlm-806	28	20	suspended	suspend	VERB
ajlm-806	28	21	pellet	pellet	NOUN
ajlm-806	28	22	and	and	CCONJ
ajlm-806	28	23	xpert	xpert	PROPN
ajlm-806	28	24	mtb	mtb	PROPN
ajlm-806	28	25	/	/	SYM
ajlm-806	28	26	rif	rif	PROPN
ajlm-806	28	27	testing	testing	NOUN
ajlm-806	28	28	was	be	AUX
ajlm-806	28	29	performed	perform	VERB
ajlm-806	28	30	as	as	ADP
ajlm-806	28	31	per	per	ADP
ajlm-806	28	32	standard	standard	ADJ
ajlm-806	28	33	procedure	procedure	NOUN
ajlm-806	28	34	described	describe	VERB
ajlm-806	28	35	by	by	ADP
ajlm-806	28	36	the	the	DET
ajlm-806	28	37	manufacture	manufacture	NOUN
ajlm-806	28	38	.	.	PUNCT
ajlm-806	29	1	acid	acid	NOUN
ajlm-806	29	2	-	-	PUNCT
ajlm-806	29	3	fast	fast	ADJ
ajlm-806	29	4	bacilli	bacilli	NOUN
ajlm-806	29	5	positive	positive	ADJ
ajlm-806	29	6	cultures	culture	NOUN
ajlm-806	29	7	were	be	AUX
ajlm-806	29	8	identified	identify	VERB
ajlm-806	29	9	using	use	VERB
ajlm-806	29	10	the	the	DET
ajlm-806	29	11	capillia	capillia	NOUN
ajlm-806	29	12	tuberculosis	tuberculosis	NOUN
ajlm-806	29	13	neo	neo	NOUN
ajlm-806	29	14	assay	assay	ADV
ajlm-806	29	15	(	(	PUNCT
ajlm-806	29	16	tauns	taun	NOUN
ajlm-806	29	17	laboratories	laboratory	NOUN
ajlm-806	29	18	,	,	PUNCT
ajlm-806	29	19	inc	inc	PROPN
ajlm-806	29	20	.	.	PROPN
ajlm-806	29	21	,	,	PUNCT
ajlm-806	29	22	shizuoka	shizuoka	PROPN
ajlm-806	29	23	,	,	PUNCT
ajlm-806	29	24	japan	japan	PROPN
ajlm-806	29	25	)	)	PUNCT
ajlm-806	29	26	to	to	PART
ajlm-806	29	27	confirm	confirm	VERB
ajlm-806	29	28	presence	presence	NOUN
ajlm-806	29	29	of	of	ADP
ajlm-806	29	30	mycobacterium	mycobacterium	NOUN
ajlm-806	29	31	tuberculosis	tuberculosis	NOUN
ajlm-806	29	32	complex.8	complex.8	NOUN
ajlm-806	29	33	confirmed	confirm	VERB
ajlm-806	29	34	m.	m.	NOUN
ajlm-806	29	35	tuberculosis	tuberculosis	ADP
ajlm-806	29	36	complex	complex	ADJ
ajlm-806	29	37	isolates	isolate	NOUN
ajlm-806	29	38	were	be	AUX
ajlm-806	29	39	tested	test	VERB
ajlm-806	29	40	for	for	ADP
ajlm-806	29	41	drug	drug	NOUN
ajlm-806	29	42	sensitivity	sensitivity	NOUN
ajlm-806	29	43	using	use	VERB
ajlm-806	29	44	the	the	DET
ajlm-806	29	45	becton	becton	PROPN
ajlm-806	29	46	dickinson	dickinson	PROPN
ajlm-806	29	47	manual	manual	NOUN
ajlm-806	29	48	mgit	mgit	ADJ
ajlm-806	29	49	sire	sire	NOUN
ajlm-806	29	50	(	(	PUNCT
ajlm-806	29	51	streptomycin	streptomycin	PROPN
ajlm-806	29	52	,	,	PUNCT
ajlm-806	29	53	isoniazid	isoniazid	NOUN
ajlm-806	29	54	,	,	PUNCT
ajlm-806	29	55	rifampicin	rifampicin	VERB
ajlm-806	29	56	,	,	PUNCT
ajlm-806	29	57	ethambutol	ethambutol	ADJ
ajlm-806	29	58	;	;	PUNCT
ajlm-806	29	59	becton	becton	PROPN
ajlm-806	29	60	dickinson	dickinson	PROPN
ajlm-806	29	61	,	,	PUNCT
ajlm-806	29	62	bergen	bergen	PROPN
ajlm-806	29	63	county	county	PROPN
ajlm-806	29	64	,	,	PUNCT
ajlm-806	29	65	new	new	PROPN
ajlm-806	29	66	jersey	jersey	PROPN
ajlm-806	29	67	,	,	PUNCT
ajlm-806	29	68	united	united	PROPN
ajlm-806	29	69	states	states	PROPN
ajlm-806	29	70	)	)	PUNCT
ajlm-806	29	71	drug	drug	NOUN
ajlm-806	29	72	susceptibility	susceptibility	NOUN
ajlm-806	29	73	testing	testing	NOUN
ajlm-806	29	74	method	method	NOUN
ajlm-806	29	75	and	and	CCONJ
ajlm-806	29	76	the	the	DET
ajlm-806	29	77	mtbdrplus	mtbdrplus	ADJ
ajlm-806	29	78	assay	assay	NOUN
ajlm-806	29	79	(	(	PUNCT
ajlm-806	29	80	version	version	NOUN
ajlm-806	29	81	1	1	NUM
ajlm-806	29	82	;	;	PUNCT
ajlm-806	29	83	hain	hain	PROPN
ajlm-806	29	84	life	life	NOUN
ajlm-806	29	85	sciences	science	NOUN
ajlm-806	29	86	,	,	PUNCT
ajlm-806	29	87	nehren	nehren	NOUN
ajlm-806	29	88	,	,	PUNCT
ajlm-806	29	89	germany	germany	PROPN
ajlm-806	29	90	)	)	PUNCT
ajlm-806	29	91	.	.	PUNCT
ajlm-806	30	1	the	the	DET
ajlm-806	30	2	drug	drug	NOUN
ajlm-806	30	3	concentrations	concentration	NOUN
ajlm-806	30	4	used	use	VERB
ajlm-806	30	5	were	be	AUX
ajlm-806	30	6	1.0	1.0	NUM
ajlm-806	30	7	µg	µg	NOUN
ajlm-806	30	8	/	/	SYM
ajlm-806	30	9	ml	ml	NOUN
ajlm-806	30	10	streptomycin	streptomycin	PROPN
ajlm-806	30	11	,	,	PUNCT
ajlm-806	30	12	0.1	0.1	NUM
ajlm-806	30	13	µg	µg	NOUN
ajlm-806	30	14	/	/	SYM
ajlm-806	30	15	ml	ml	NOUN
ajlm-806	30	16	isoniazid	isoniazid	NOUN
ajlm-806	30	17	,	,	PUNCT
ajlm-806	30	18	1.0	1.0	NUM
ajlm-806	30	19	µg	µg	NOUN
ajlm-806	30	20	/	/	SYM
ajlm-806	30	21	ml	ml	VERB
ajlm-806	30	22	rifampicin	rifampicin	VERB
ajlm-806	30	23	,	,	PUNCT
ajlm-806	30	24	and	and	CCONJ
ajlm-806	30	25	5.0	5.0	NUM
ajlm-806	30	26	µg	µg	NOUN
ajlm-806	30	27	/	/	SYM
ajlm-806	30	28	ml	ml	NOUN
ajlm-806	30	29	ethambutol	ethambutol	ADJ
ajlm-806	30	30	.	.	PUNCT
ajlm-806	31	1	the	the	DET
ajlm-806	31	2	mgit	mgit	PROPN
ajlm-806	31	3	sire	sire	NOUN
ajlm-806	31	4	tubes	tube	NOUN
ajlm-806	31	5	were	be	AUX
ajlm-806	31	6	read	read	VERB
ajlm-806	31	7	daily	daily	ADV
ajlm-806	31	8	as	as	ADP
ajlm-806	31	9	per	per	ADP
ajlm-806	31	10	the	the	DET
ajlm-806	31	11	manufacturer	manufacturer	NOUN
ajlm-806	31	12	’s	’s	PART
ajlm-806	31	13	recommendation	recommendation	NOUN
ajlm-806	31	14	.	.	PUNCT
ajlm-806	32	1	to	to	PART
ajlm-806	32	2	perform	perform	VERB
ajlm-806	32	3	the	the	DET
ajlm-806	32	4	mtbdrplus	mtbdrplus	ADJ
ajlm-806	32	5	assay	assay	NOUN
ajlm-806	32	6	,	,	PUNCT
ajlm-806	32	7	1	1	NUM
ajlm-806	32	8	ml	ml	NOUN
ajlm-806	32	9	of	of	ADP
ajlm-806	32	10	broth	broth	NOUN
ajlm-806	32	11	from	from	ADP
ajlm-806	32	12	an	an	DET
ajlm-806	32	13	m.	m.	NOUN
ajlm-806	32	14	tuberculosis	tuberculosis	NOUN
ajlm-806	32	15	complex	complex	ADJ
ajlm-806	32	16	culture	culture	NOUN
ajlm-806	32	17	-	-	PUNCT
ajlm-806	32	18	positive	positive	ADJ
ajlm-806	32	19	mgit	mgit	ADJ
ajlm-806	32	20	tube	tube	NOUN
ajlm-806	32	21	was	be	AUX
ajlm-806	32	22	used	use	VERB
ajlm-806	32	23	for	for	ADP
ajlm-806	32	24	dna	dna	NOUN
ajlm-806	32	25	extraction	extraction	NOUN
ajlm-806	32	26	using	use	VERB
ajlm-806	32	27	the	the	DET
ajlm-806	32	28	genolyse	genolyse	PROPN
ajlm-806	32	29	method	method	NOUN
ajlm-806	32	30	.	.	PUNCT
ajlm-806	33	1	briefly	briefly	NOUN
ajlm-806	33	2	,	,	PUNCT
ajlm-806	33	3	1	1	NUM
ajlm-806	33	4	ml	ml	NOUN
ajlm-806	33	5	of	of	ADP
ajlm-806	33	6	culture	culture	NOUN
ajlm-806	33	7	broth	broth	NOUN
ajlm-806	33	8	was	be	AUX
ajlm-806	33	9	centrifuged	centrifuge	VERB
ajlm-806	33	10	,	,	PUNCT
ajlm-806	33	11	the	the	DET
ajlm-806	33	12	pellet	pellet	NOUN
ajlm-806	33	13	was	be	AUX
ajlm-806	33	14	incubated	incubate	VERB
ajlm-806	33	15	for	for	ADP
ajlm-806	33	16	5	5	NUM
ajlm-806	33	17	minutes	minute	NOUN
ajlm-806	33	18	at	at	ADP
ajlm-806	33	19	95	95	NUM
ajlm-806	33	20	°	°	ADP
ajlm-806	33	21	c	c	NOUN
ajlm-806	33	22	in	in	ADP
ajlm-806	33	23	lysis	lysis	NOUN
ajlm-806	33	24	buffer	buffer	NOUN
ajlm-806	33	25	after	after	ADP
ajlm-806	33	26	which	which	PRON
ajlm-806	33	27	a	a	DET
ajlm-806	33	28	neutralisation	neutralisation	NOUN
ajlm-806	33	29	buffer	buffer	NOUN
ajlm-806	33	30	was	be	AUX
ajlm-806	33	31	added	add	VERB
ajlm-806	33	32	.	.	PUNCT
ajlm-806	34	1	subsequent	subsequent	ADJ
ajlm-806	34	2	steps	step	NOUN
ajlm-806	34	3	for	for	ADP
ajlm-806	34	4	polymerase	polymerase	NOUN
ajlm-806	34	5	chain	chain	NOUN
ajlm-806	34	6	reaction	reaction	NOUN
ajlm-806	34	7	and	and	CCONJ
ajlm-806	34	8	hybridisation	hybridisation	NOUN
ajlm-806	34	9	were	be	AUX
ajlm-806	34	10	followed	follow	VERB
ajlm-806	34	11	as	as	ADP
ajlm-806	34	12	per	per	ADP
ajlm-806	34	13	standard	standard	ADJ
ajlm-806	34	14	procedure	procedure	NOUN
ajlm-806	34	15	for	for	ADP
ajlm-806	34	16	mtbdrplus	mtbdrplus	ADJ
ajlm-806	34	17	testing.9	testing.9	PROPN
ajlm-806	34	18	all	all	DET
ajlm-806	34	19	procedures	procedure	NOUN
ajlm-806	34	20	included	include	VERB
ajlm-806	34	21	positive	positive	ADJ
ajlm-806	34	22	and	and	CCONJ
ajlm-806	34	23	negative	negative	ADJ
ajlm-806	34	24	controls	control	NOUN
ajlm-806	34	25	.	.	PUNCT
ajlm-806	35	1	the	the	DET
ajlm-806	35	2	data	datum	NOUN
ajlm-806	35	3	were	be	AUX
ajlm-806	35	4	analysed	analyse	VERB
ajlm-806	35	5	using	use	VERB
ajlm-806	35	6	stata	stata	NOUN
ajlm-806	35	7	version	version	NOUN
ajlm-806	35	8	13	13	NUM
ajlm-806	35	9	(	(	PUNCT
ajlm-806	35	10	statacorp	statacorp	PROPN
ajlm-806	35	11	llc	llc	PROPN
ajlm-806	35	12	,	,	PUNCT
ajlm-806	35	13	college	college	NOUN
ajlm-806	35	14	station	station	NOUN
ajlm-806	35	15	,	,	PUNCT
ajlm-806	35	16	texas	texas	PROPN
ajlm-806	35	17	,	,	PUNCT
ajlm-806	35	18	united	united	PROPN
ajlm-806	35	19	states	states	PROPN
ajlm-806	35	20	)	)	PUNCT
ajlm-806	35	21	.	.	PUNCT
ajlm-806	36	1	an	an	DET
ajlm-806	36	2	initial	initial	ADJ
ajlm-806	36	3	descriptive	descriptive	ADJ
ajlm-806	36	4	analysis	analysis	NOUN
ajlm-806	36	5	was	be	AUX
ajlm-806	36	6	done	do	VERB
ajlm-806	36	7	to	to	PART
ajlm-806	36	8	determine	determine	VERB
ajlm-806	36	9	the	the	DET
ajlm-806	36	10	distribution	distribution	NOUN
ajlm-806	36	11	of	of	ADP
ajlm-806	36	12	results	result	NOUN
ajlm-806	36	13	,	,	PUNCT
ajlm-806	36	14	then	then	ADV
ajlm-806	36	15	the	the	DET
ajlm-806	36	16	xpert	xpert	PROPN
ajlm-806	36	17	mtb	mtb	PROPN
ajlm-806	36	18	/	/	SYM
ajlm-806	36	19	rif	rif	PROPN
ajlm-806	36	20	results	result	NOUN
ajlm-806	36	21	obtained	obtain	VERB
ajlm-806	36	22	at	at	ADP
ajlm-806	36	23	the	the	DET
ajlm-806	36	24	primary	primary	ADJ
ajlm-806	36	25	health	health	NOUN
ajlm-806	36	26	care	care	NOUN
ajlm-806	36	27	setting	setting	NOUN
ajlm-806	36	28	were	be	AUX
ajlm-806	36	29	compared	compare	VERB
ajlm-806	36	30	with	with	ADP
ajlm-806	36	31	the	the	DET
ajlm-806	36	32	results	result	NOUN
ajlm-806	36	33	obtained	obtain	VERB
ajlm-806	36	34	at	at	ADP
ajlm-806	36	35	the	the	DET
ajlm-806	36	36	central	central	ADJ
ajlm-806	36	37	laboratory	laboratory	NOUN
ajlm-806	36	38	.	.	PUNCT
ajlm-806	37	1	further	further	ADJ
ajlm-806	37	2	analysis	analysis	NOUN
ajlm-806	37	3	was	be	AUX
ajlm-806	37	4	done	do	VERB
ajlm-806	37	5	to	to	PART
ajlm-806	37	6	compare	compare	VERB
ajlm-806	37	7	the	the	DET
ajlm-806	37	8	performance	performance	NOUN
ajlm-806	37	9	of	of	ADP
ajlm-806	37	10	xpert	xpert	PROPN
ajlm-806	37	11	mtb	mtb	PROPN
ajlm-806	37	12	/	/	SYM
ajlm-806	37	13	rif	rif	PROPN
ajlm-806	37	14	,	,	PUNCT
ajlm-806	37	15	mtbdrplus	mtbdrplus	ADJ
ajlm-806	37	16	and	and	CCONJ
ajlm-806	37	17	mgit	mgit	ADJ
ajlm-806	37	18	m.	m.	NOUN
ajlm-806	37	19	tuberculosis	tuberculosis	NOUN
ajlm-806	37	20	drug	drug	NOUN
ajlm-806	37	21	susceptibility	susceptibility	NOUN
ajlm-806	37	22	testing	testing	NOUN
ajlm-806	37	23	and	and	CCONJ
ajlm-806	37	24	to	to	PART
ajlm-806	37	25	determine	determine	VERB
ajlm-806	37	26	the	the	DET
ajlm-806	37	27	sensitivity	sensitivity	NOUN
ajlm-806	37	28	and	and	CCONJ
ajlm-806	37	29	specificity	specificity	NOUN
ajlm-806	37	30	of	of	ADP
ajlm-806	37	31	xpert	xpert	PROPN
ajlm-806	37	32	mtb	mtb	PROPN
ajlm-806	37	33	/	/	SYM
ajlm-806	37	34	rif	rif	PROPN
ajlm-806	37	35	and	and	CCONJ
ajlm-806	37	36	mtbdrplus	mtbdrplus	ADJ
ajlm-806	37	37	compared	compare	VERB
ajlm-806	37	38	to	to	ADP
ajlm-806	37	39	the	the	DET
ajlm-806	37	40	gold	gold	ADJ
ajlm-806	37	41	standard	standard	ADJ
ajlm-806	37	42	mgit	mgit	ADJ
ajlm-806	37	43	culture	culture	NOUN
ajlm-806	37	44	for	for	ADP
ajlm-806	37	45	drug	drug	NOUN
ajlm-806	37	46	susceptibility	susceptibility	NOUN
ajlm-806	37	47	testing	testing	NOUN
ajlm-806	37	48	.	.	PUNCT
ajlm-806	38	1	results	result	NOUN
ajlm-806	38	2	during	during	ADP
ajlm-806	38	3	the	the	DET
ajlm-806	38	4	study	study	NOUN
ajlm-806	38	5	period	period	NOUN
ajlm-806	38	6	,	,	PUNCT
ajlm-806	38	7	1070	1070	NUM
ajlm-806	38	8	patients	patient	NOUN
ajlm-806	38	9	had	have	VERB
ajlm-806	38	10	m.	m.	NOUN
ajlm-806	38	11	tuberculosis	tuberculosis	PRON
ajlm-806	38	12	complex	complex	ADJ
ajlm-806	38	13	detected	detect	VERB
ajlm-806	38	14	by	by	ADP
ajlm-806	38	15	the	the	DET
ajlm-806	38	16	xpert	xpert	PROPN
ajlm-806	38	17	mtb	mtb	PROPN
ajlm-806	38	18	/	/	SYM
ajlm-806	38	19	rif	rif	PROPN
ajlm-806	38	20	test	test	NOUN
ajlm-806	38	21	.	.	PUNCT
ajlm-806	39	1	of	of	ADP
ajlm-806	39	2	these	these	PRON
ajlm-806	39	3	,	,	PUNCT
ajlm-806	39	4	28	28	NUM
ajlm-806	39	5	(	(	PUNCT
ajlm-806	39	6	2.6	2.6	NUM
ajlm-806	39	7	%	%	NOUN
ajlm-806	39	8	)	)	PUNCT
ajlm-806	39	9	were	be	AUX
ajlm-806	39	10	positive	positive	ADJ
ajlm-806	39	11	for	for	ADP
ajlm-806	39	12	rifampicin	rifampicin	VERB
ajlm-806	39	13	resistance	resistance	NOUN
ajlm-806	39	14	and	and	CCONJ
ajlm-806	39	15	15	15	NUM
ajlm-806	39	16	(	(	PUNCT
ajlm-806	39	17	1.4	1.4	NUM
ajlm-806	39	18	%	%	NOUN
ajlm-806	39	19	)	)	PUNCT
ajlm-806	39	20	had	have	AUX
ajlm-806	39	21	indeterminate	indeterminate	VERB
ajlm-806	39	22	rifampicin	rifampicin	VERB
ajlm-806	39	23	resistance	resistance	NOUN
ajlm-806	39	24	results	result	NOUN
ajlm-806	39	25	.	.	PUNCT
ajlm-806	40	1	of	of	ADP
ajlm-806	40	2	the	the	DET
ajlm-806	40	3	43	43	NUM
ajlm-806	40	4	patients	patient	NOUN
ajlm-806	40	5	eligible	eligible	ADJ
ajlm-806	40	6	for	for	ADP
ajlm-806	40	7	inclusion	inclusion	NOUN
ajlm-806	40	8	in	in	ADP
ajlm-806	40	9	the	the	DET
ajlm-806	40	10	study	study	NOUN
ajlm-806	40	11	(	(	PUNCT
ajlm-806	40	12	i.e.	i.e.	X
ajlm-806	40	13	had	have	VERB
ajlm-806	40	14	rifampicin	rifampicin	VERB
ajlm-806	40	15	-	-	PUNCT
ajlm-806	40	16	resistant	resistant	ADJ
ajlm-806	40	17	or	or	CCONJ
ajlm-806	40	18	rifampicin	rifampicin	NOUN
ajlm-806	40	19	-	-	PUNCT
ajlm-806	40	20	indeterminate	indeterminate	NOUN
ajlm-806	40	21	xpert	xpert	PROPN
ajlm-806	40	22	mtb	mtb	PROPN
ajlm-806	40	23	/	/	SYM
ajlm-806	40	24	rif	rif	PROPN
ajlm-806	40	25	results	results	PROPN
ajlm-806	40	26	)	)	PUNCT
ajlm-806	40	27	,	,	PUNCT
ajlm-806	40	28	only	only	ADV
ajlm-806	40	29	30	30	NUM
ajlm-806	40	30	submitted	submit	VERB
ajlm-806	40	31	samples	sample	NOUN
ajlm-806	40	32	for	for	ADP
ajlm-806	40	33	further	further	ADJ
ajlm-806	40	34	testing	testing	NOUN
ajlm-806	40	35	at	at	ADP
ajlm-806	40	36	the	the	DET
ajlm-806	40	37	central	central	ADJ
ajlm-806	40	38	laboratory	laboratory	NOUN
ajlm-806	40	39	(	(	PUNCT
ajlm-806	40	40	table	table	NOUN
ajlm-806	40	41	1	1	NUM
ajlm-806	40	42	)	)	PUNCT
ajlm-806	40	43	.	.	PUNCT
ajlm-806	41	1	of	of	ADP
ajlm-806	41	2	these	these	PRON
ajlm-806	41	3	,	,	PUNCT
ajlm-806	41	4	21	21	NUM
ajlm-806	41	5	(	(	PUNCT
ajlm-806	41	6	70	70	NUM
ajlm-806	41	7	%	%	NOUN
ajlm-806	41	8	)	)	PUNCT
ajlm-806	41	9	were	be	AUX
ajlm-806	41	10	positive	positive	ADJ
ajlm-806	41	11	for	for	ADP
ajlm-806	41	12	both	both	PRON
ajlm-806	41	13	m.	m.	NOUN
ajlm-806	41	14	tuberculosis	tuberculosis	NOUN
ajlm-806	41	15	and	and	CCONJ
ajlm-806	41	16	rifampicin	rifampicin	VERB
ajlm-806	41	17	resistance	resistance	NOUN
ajlm-806	41	18	,	,	PUNCT
ajlm-806	41	19	and	and	CCONJ
ajlm-806	41	20	nine	nine	NUM
ajlm-806	41	21	(	(	PUNCT
ajlm-806	41	22	30	30	NUM
ajlm-806	41	23	%	%	NOUN
ajlm-806	41	24	)	)	PUNCT
ajlm-806	41	25	were	be	AUX
ajlm-806	41	26	positive	positive	ADJ
ajlm-806	41	27	for	for	ADP
ajlm-806	41	28	m.	m.	NOUN
ajlm-806	41	29	tuberculosis	tuberculosis	NOUN
ajlm-806	41	30	but	but	CCONJ
ajlm-806	41	31	indeterminate	indeterminate	VERB
ajlm-806	41	32	for	for	ADP
ajlm-806	41	33	rifampicin	rifampicin	VERB
ajlm-806	41	34	resistance	resistance	NOUN
ajlm-806	41	35	.	.	PUNCT
ajlm-806	42	1	on	on	ADP
ajlm-806	42	2	repeat	repeat	PROPN
ajlm-806	42	3	xpert	xpert	PROPN
ajlm-806	42	4	mtb	mtb	PROPN
ajlm-806	42	5	/	/	SYM
ajlm-806	42	6	rif	rif	PROPN
ajlm-806	42	7	testing	testing	NOUN
ajlm-806	42	8	at	at	ADP
ajlm-806	42	9	the	the	DET
ajlm-806	42	10	central	central	ADJ
ajlm-806	42	11	laboratory	laboratory	NOUN
ajlm-806	42	12	,	,	PUNCT
ajlm-806	42	13	of	of	ADP
ajlm-806	42	14	the	the	DET
ajlm-806	42	15	21	21	NUM
ajlm-806	42	16	patients	patient	NOUN
ajlm-806	42	17	initially	initially	ADV
ajlm-806	42	18	positive	positive	ADJ
ajlm-806	42	19	for	for	ADP
ajlm-806	42	20	rifampicin	rifampicin	VERB
ajlm-806	42	21	resistance	resistance	NOUN
ajlm-806	42	22	,	,	PUNCT
ajlm-806	42	23	17	17	NUM
ajlm-806	42	24	(	(	PUNCT
ajlm-806	42	25	81	81	NUM
ajlm-806	42	26	%	%	NOUN
ajlm-806	42	27	)	)	PUNCT
ajlm-806	42	28	were	be	AUX
ajlm-806	42	29	again	again	ADV
ajlm-806	42	30	positive	positive	ADJ
ajlm-806	42	31	for	for	ADP
ajlm-806	42	32	rifampicin	rifampicin	VERB
ajlm-806	42	33	resistance	resistance	NOUN
ajlm-806	42	34	,	,	PUNCT
ajlm-806	42	35	three	three	NUM
ajlm-806	42	36	(	(	PUNCT
ajlm-806	42	37	14	14	NUM
ajlm-806	42	38	%	%	NOUN
ajlm-806	42	39	)	)	PUNCT
ajlm-806	42	40	were	be	AUX
ajlm-806	42	41	negative	negative	ADJ
ajlm-806	42	42	for	for	ADP
ajlm-806	42	43	rifampicin	rifampicin	VERB
ajlm-806	42	44	resistance	resistance	NOUN
ajlm-806	42	45	and	and	CCONJ
ajlm-806	42	46	one	one	NUM
ajlm-806	42	47	(	(	PUNCT
ajlm-806	42	48	5	5	NUM
ajlm-806	42	49	%	%	NOUN
ajlm-806	42	50	)	)	PUNCT
ajlm-806	42	51	tested	test	VERB
ajlm-806	42	52	negative	negative	ADJ
ajlm-806	42	53	for	for	ADP
ajlm-806	42	54	m.	m.	NOUN
ajlm-806	42	55	tuberculosis	tuberculosis	NOUN
ajlm-806	42	56	.	.	PUNCT
ajlm-806	43	1	table	table	NOUN
ajlm-806	43	2	1	1	NUM
ajlm-806	43	3	:	:	PUNCT
ajlm-806	43	4	 	 	SPACE
ajlm-806	43	5	comparison	comparison	NOUN
ajlm-806	43	6	of	of	ADP
ajlm-806	43	7	xpert	xpert	PROPN
ajlm-806	43	8	mtb	mtb	PROPN
ajlm-806	43	9	/	/	SYM
ajlm-806	43	10	rif	rif	PROPN
ajlm-806	43	11	testing	testing	NOUN
ajlm-806	43	12	at	at	ADP
ajlm-806	43	13	the	the	DET
ajlm-806	43	14	primary	primary	ADJ
ajlm-806	43	15	health	health	NOUN
ajlm-806	43	16	care	care	NOUN
ajlm-806	43	17	facility	facility	PROPN
ajlm-806	43	18	peripheral	peripheral	ADJ
ajlm-806	43	19	laboratory	laboratory	NOUN
ajlm-806	43	20	to	to	ADP
ajlm-806	43	21	xpert	xpert	PROPN
ajlm-806	43	22	mtb	mtb	PROPN
ajlm-806	43	23	/	/	SYM
ajlm-806	43	24	rif	rif	PROPN
ajlm-806	43	25	testing	testing	NOUN
ajlm-806	43	26	at	at	ADP
ajlm-806	43	27	the	the	DET
ajlm-806	43	28	central	central	ADJ
ajlm-806	43	29	laboratory	laboratory	NOUN
ajlm-806	43	30	,	,	PUNCT
ajlm-806	43	31	zambia	zambia	PROPN
ajlm-806	43	32	,	,	PUNCT
ajlm-806	43	33	march	march	PROPN
ajlm-806	43	34	2012	2012	NUM
ajlm-806	43	35	and	and	CCONJ
ajlm-806	43	36	march	march	PROPN
ajlm-806	43	37	2014	2014	NUM
ajlm-806	43	38	.	.	PUNCT
ajlm-806	44	1	of	of	ADP
ajlm-806	44	2	the	the	DET
ajlm-806	44	3	nine	nine	NUM
ajlm-806	44	4	patients	patient	NOUN
ajlm-806	44	5	initially	initially	ADV
ajlm-806	44	6	indeterminate	indeterminate	VERB
ajlm-806	44	7	for	for	ADP
ajlm-806	44	8	rifampicin	rifampicin	VERB
ajlm-806	44	9	resistance	resistance	NOUN
ajlm-806	44	10	,	,	PUNCT
ajlm-806	44	11	five	five	NUM
ajlm-806	44	12	(	(	PUNCT
ajlm-806	44	13	56	56	NUM
ajlm-806	44	14	%	%	NOUN
ajlm-806	44	15	)	)	PUNCT
ajlm-806	44	16	tested	test	VERB
ajlm-806	44	17	negative	negative	ADJ
ajlm-806	44	18	for	for	ADP
ajlm-806	44	19	rifampicin	rifampicin	VERB
ajlm-806	44	20	resistance	resistance	NOUN
ajlm-806	44	21	and	and	CCONJ
ajlm-806	44	22	four	four	NUM
ajlm-806	44	23	(	(	PUNCT
ajlm-806	44	24	44	44	NUM
ajlm-806	44	25	%	%	NOUN
ajlm-806	44	26	)	)	PUNCT
ajlm-806	44	27	tested	test	VERB
ajlm-806	44	28	negative	negative	ADJ
ajlm-806	44	29	for	for	ADP
ajlm-806	44	30	m.	m.	NOUN
ajlm-806	44	31	tuberculosis	tuberculosis	NOUN
ajlm-806	44	32	on	on	ADP
ajlm-806	44	33	repeat	repeat	PROPN
ajlm-806	44	34	xpert	xpert	PROPN
ajlm-806	44	35	mtb	mtb	PROPN
ajlm-806	44	36	/	/	SYM
ajlm-806	44	37	rif	rif	PROPN
ajlm-806	44	38	testing	testing	NOUN
ajlm-806	44	39	(	(	PUNCT
ajlm-806	44	40	table	table	NOUN
ajlm-806	44	41	1	1	NUM
ajlm-806	44	42	)	)	PUNCT
ajlm-806	44	43	.	.	PUNCT
ajlm-806	45	1	these	these	DET
ajlm-806	45	2	four	four	NUM
ajlm-806	45	3	(	(	PUNCT
ajlm-806	45	4	44	44	NUM
ajlm-806	45	5	%	%	NOUN
ajlm-806	45	6	)	)	PUNCT
ajlm-806	45	7	samples	sample	NOUN
ajlm-806	45	8	negative	negative	ADJ
ajlm-806	45	9	for	for	ADP
ajlm-806	45	10	m.	m.	NOUN
ajlm-806	45	11	tuberculosis	tuberculosis	NOUN
ajlm-806	45	12	on	on	ADP
ajlm-806	45	13	repeat	repeat	PROPN
ajlm-806	45	14	xpert	xpert	PROPN
ajlm-806	45	15	mtb	mtb	PROPN
ajlm-806	45	16	/	/	SYM
ajlm-806	45	17	rif	rif	PROPN
ajlm-806	45	18	testing	testing	NOUN
ajlm-806	45	19	were	be	AUX
ajlm-806	45	20	m.	m.	NOUN
ajlm-806	45	21	tuberculosis	tuberculosis	ADP
ajlm-806	45	22	positive	positive	ADJ
ajlm-806	45	23	but	but	CCONJ
ajlm-806	45	24	rifampicin	rifampicin	VERB
ajlm-806	45	25	resistance	resistance	NOUN
ajlm-806	45	26	negative	negative	ADJ
ajlm-806	45	27	when	when	SCONJ
ajlm-806	45	28	tested	test	VERB
ajlm-806	45	29	by	by	ADP
ajlm-806	45	30	both	both	CCONJ
ajlm-806	45	31	mtbdrplus	mtbdrplus	ADJ
ajlm-806	45	32	and	and	CCONJ
ajlm-806	45	33	mgit	mgit	ADJ
ajlm-806	45	34	drug	drug	NOUN
ajlm-806	45	35	susceptibility	susceptibility	NOUN
ajlm-806	45	36	testing	testing	NOUN
ajlm-806	45	37	(	(	PUNCT
ajlm-806	45	38	tables	table	NOUN
ajlm-806	45	39	2–3	2–3	NUM
ajlm-806	45	40	)	)	PUNCT
ajlm-806	45	41	.	.	PUNCT
ajlm-806	46	1	xpert	xpert	PROPN
ajlm-806	46	2	mtb	mtb	PROPN
ajlm-806	46	3	/	/	SYM
ajlm-806	46	4	rif	rif	PROPN
ajlm-806	46	5	and	and	CCONJ
ajlm-806	46	6	mtbdrplus	mtbdrplus	ADJ
ajlm-806	46	7	were	be	AUX
ajlm-806	46	8	100	100	NUM
ajlm-806	46	9	%	%	NOUN
ajlm-806	46	10	concordant	concordant	ADJ
ajlm-806	46	11	for	for	ADP
ajlm-806	46	12	detection	detection	NOUN
ajlm-806	46	13	of	of	ADP
ajlm-806	46	14	rifampicin	rifampicin	VERB
ajlm-806	46	15	resistance	resistance	NOUN
ajlm-806	46	16	(	(	PUNCT
ajlm-806	46	17	table	table	NOUN
ajlm-806	46	18	2	2	NUM
ajlm-806	46	19	)	)	PUNCT
ajlm-806	46	20	.	.	PUNCT
ajlm-806	47	1	when	when	SCONJ
ajlm-806	47	2	compared	compare	VERB
ajlm-806	47	3	to	to	ADP
ajlm-806	47	4	mgit	mgit	ADJ
ajlm-806	47	5	drug	drug	NOUN
ajlm-806	47	6	susceptibility	susceptibility	NOUN
ajlm-806	47	7	testing	testing	NOUN
ajlm-806	47	8	,	,	PUNCT
ajlm-806	47	9	the	the	DET
ajlm-806	47	10	sensitivity	sensitivity	NOUN
ajlm-806	47	11	of	of	ADP
ajlm-806	47	12	xpert	xpert	PROPN
ajlm-806	47	13	mtb	mtb	PROPN
ajlm-806	47	14	/	/	SYM
ajlm-806	47	15	rif	rif	PROPN
ajlm-806	47	16	and	and	CCONJ
ajlm-806	47	17	mtbdrplus	mtbdrplus	ADJ
ajlm-806	47	18	for	for	ADP
ajlm-806	47	19	detection	detection	NOUN
ajlm-806	47	20	of	of	ADP
ajlm-806	47	21	rifampicin	rifampicin	VERB
ajlm-806	47	22	resistance	resistance	NOUN
ajlm-806	47	23	was	be	AUX
ajlm-806	47	24	100	100	NUM
ajlm-806	47	25	%	%	NOUN
ajlm-806	47	26	,	,	PUNCT
ajlm-806	47	27	while	while	SCONJ
ajlm-806	47	28	specificity	specificity	NOUN
ajlm-806	47	29	was	be	AUX
ajlm-806	47	30	72	72	NUM
ajlm-806	47	31	%	%	NOUN
ajlm-806	47	32	for	for	ADP
ajlm-806	47	33	xpert	xpert	PROPN
ajlm-806	47	34	mtb	mtb	PROPN
ajlm-806	47	35	/	/	SYM
ajlm-806	47	36	rif	rif	PROPN
ajlm-806	47	37	and	and	CCONJ
ajlm-806	47	38	80	80	NUM
ajlm-806	47	39	%	%	NOUN
ajlm-806	47	40	for	for	ADP
ajlm-806	47	41	mtbdrplus	mtbdrplus	ADJ
ajlm-806	47	42	.	.	PUNCT
ajlm-806	48	1	three	three	NUM
ajlm-806	48	2	patients	patient	NOUN
ajlm-806	48	3	had	have	VERB
ajlm-806	48	4	positive	positive	ADJ
ajlm-806	48	5	rifampicin	rifampicin	VERB
ajlm-806	48	6	resistance	resistance	NOUN
ajlm-806	48	7	results	result	NOUN
ajlm-806	48	8	on	on	ADP
ajlm-806	48	9	both	both	CCONJ
ajlm-806	48	10	xpert	xpert	PROPN
ajlm-806	48	11	mtb	mtb	PROPN
ajlm-806	48	12	/	/	SYM
ajlm-806	48	13	rif	rif	PROPN
ajlm-806	48	14	and	and	CCONJ
ajlm-806	48	15	mtbdrplus	mtbdrplus	ADJ
ajlm-806	48	16	(	(	PUNCT
ajlm-806	48	17	table	table	NOUN
ajlm-806	48	18	2	2	NUM
ajlm-806	48	19	)	)	PUNCT
ajlm-806	48	20	,	,	PUNCT
ajlm-806	48	21	but	but	CCONJ
ajlm-806	48	22	rifampicin	rifampicin	VERB
ajlm-806	48	23	resistance	resistance	NOUN
ajlm-806	48	24	was	be	AUX
ajlm-806	48	25	not	not	PART
ajlm-806	48	26	detected	detect	VERB
ajlm-806	48	27	with	with	ADP
ajlm-806	48	28	mgit	mgit	ADJ
ajlm-806	48	29	drug	drug	NOUN
ajlm-806	48	30	susceptibility	susceptibility	NOUN
ajlm-806	48	31	testing	testing	NOUN
ajlm-806	48	32	(	(	PUNCT
ajlm-806	48	33	tables	table	NOUN
ajlm-806	48	34	3	3	NUM
ajlm-806	48	35	and	and	CCONJ
ajlm-806	48	36	4	4	NUM
ajlm-806	48	37	)	)	PUNCT
ajlm-806	48	38	.	.	PUNCT
ajlm-806	49	1	on	on	ADP
ajlm-806	49	2	xpert	xpert	PROPN
ajlm-806	49	3	mtb	mtb	PROPN
ajlm-806	49	4	/	/	SYM
ajlm-806	49	5	rif	rif	PROPN
ajlm-806	49	6	all	all	DET
ajlm-806	49	7	three	three	NUM
ajlm-806	49	8	samples	sample	NOUN
ajlm-806	49	9	showed	show	VERB
ajlm-806	49	10	no	no	DET
ajlm-806	49	11	signal	signal	NOUN
ajlm-806	49	12	for	for	ADP
ajlm-806	49	13	probe	probe	NOUN
ajlm-806	49	14	d	d	NOUN
ajlm-806	49	15	and	and	CCONJ
ajlm-806	49	16	on	on	ADP
ajlm-806	49	17	mtbdrplus	mtbdrplus	ADJ
ajlm-806	49	18	,	,	PUNCT
ajlm-806	49	19	all	all	PRON
ajlm-806	49	20	were	be	AUX
ajlm-806	49	21	missing	miss	VERB
ajlm-806	49	22	the	the	DET
ajlm-806	49	23	wild	wild	ADJ
ajlm-806	49	24	-	-	PUNCT
ajlm-806	49	25	type	type	NOUN
ajlm-806	49	26	7	7	NUM
ajlm-806	49	27	probe	probe	NOUN
ajlm-806	49	28	and	and	CCONJ
ajlm-806	49	29	showed	show	VERB
ajlm-806	49	30	no	no	DET
ajlm-806	49	31	mutation	mutation	NOUN
ajlm-806	49	32	probe	probe	NOUN
ajlm-806	49	33	(	(	PUNCT
ajlm-806	49	34	results	result	NOUN
ajlm-806	49	35	not	not	PART
ajlm-806	49	36	shown	show	VERB
ajlm-806	49	37	)	)	PUNCT
ajlm-806	49	38	.	.	PUNCT
ajlm-806	50	1	these	these	DET
ajlm-806	50	2	three	three	NUM
ajlm-806	50	3	isolates	isolate	NOUN
ajlm-806	50	4	were	be	AUX
ajlm-806	50	5	also	also	ADV
ajlm-806	50	6	resistant	resistant	ADJ
ajlm-806	50	7	to	to	ADP
ajlm-806	50	8	isoniazid	isoniazid	NOUN
ajlm-806	50	9	on	on	ADP
ajlm-806	50	10	both	both	PRON
ajlm-806	50	11	mgit	mgit	ADJ
ajlm-806	50	12	drug	drug	NOUN
ajlm-806	50	13	susceptibility	susceptibility	NOUN
ajlm-806	50	14	testing	testing	NOUN
ajlm-806	50	15	and	and	CCONJ
ajlm-806	50	16	mtbdrplus	mtbdrplus	ADJ
ajlm-806	50	17	(	(	PUNCT
ajlm-806	50	18	tables	table	NOUN
ajlm-806	50	19	3	3	NUM
ajlm-806	50	20	and	and	CCONJ
ajlm-806	50	21	4	4	NUM
ajlm-806	50	22	)	)	PUNCT
ajlm-806	50	23	.	.	PUNCT
ajlm-806	51	1	table	table	NOUN
ajlm-806	51	2	2	2	NUM
ajlm-806	51	3	:	:	PUNCT
ajlm-806	51	4	 	 	SPACE
ajlm-806	51	5	comparison	comparison	NOUN
ajlm-806	51	6	of	of	ADP
ajlm-806	51	7	repeat	repeat	PROPN
ajlm-806	51	8	xpert	xpert	PROPN
ajlm-806	51	9	mtb	mtb	PROPN
ajlm-806	51	10	/	/	SYM
ajlm-806	51	11	rif	rif	PROPN
ajlm-806	51	12	and	and	CCONJ
ajlm-806	51	13	mtbdrplus	mtbdrplus	ADJ
ajlm-806	51	14	test	test	NOUN
ajlm-806	51	15	results	result	NOUN
ajlm-806	51	16	.	.	PUNCT
ajlm-806	52	1	table	table	NOUN
ajlm-806	52	2	3	3	NUM
ajlm-806	52	3	:	:	PUNCT
ajlm-806	52	4	 	 	SPACE
ajlm-806	52	5	comparison	comparison	NOUN
ajlm-806	52	6	of	of	ADP
ajlm-806	52	7	repeat	repeat	PROPN
ajlm-806	52	8	xpert	xpert	PROPN
ajlm-806	52	9	mtb	mtb	PROPN
ajlm-806	52	10	/	/	SYM
ajlm-806	52	11	rif	rif	PROPN
ajlm-806	52	12	and	and	CCONJ
ajlm-806	52	13	mycobacterium	mycobacterium	NOUN
ajlm-806	52	14	growth	growth	NOUN
ajlm-806	52	15	indicator	indicator	NOUN
ajlm-806	52	16	tube	tube	NOUN
ajlm-806	52	17	mycobacterium	mycobacterium	NOUN
ajlm-806	52	18	tuberculosis	tuberculosis	NOUN
ajlm-806	52	19	drug	drug	NOUN
ajlm-806	52	20	susceptibility	susceptibility	NOUN
ajlm-806	52	21	testing	testing	NOUN
ajlm-806	52	22	.	.	PUNCT
ajlm-806	53	1	table	table	NOUN
ajlm-806	53	2	4	4	NUM
ajlm-806	53	3	:	:	PUNCT
ajlm-806	53	4	 	 	SPACE
ajlm-806	53	5	comparison	comparison	NOUN
ajlm-806	53	6	of	of	ADP
ajlm-806	53	7	mtbdrplus	mtbdrplus	ADJ
ajlm-806	53	8	and	and	CCONJ
ajlm-806	53	9	mycobacterium	mycobacterium	NOUN
ajlm-806	53	10	growth	growth	NOUN
ajlm-806	53	11	indicator	indicator	NOUN
ajlm-806	53	12	tube	tube	NOUN
ajlm-806	53	13	mycobacterium	mycobacterium	NOUN
ajlm-806	53	14	tuberculosis	tuberculosis	NOUN
ajlm-806	53	15	drug	drug	NOUN
ajlm-806	53	16	susceptibility	susceptibility	NOUN
ajlm-806	53	17	testing	testing	NOUN
ajlm-806	53	18	.	.	PUNCT
ajlm-806	54	1	the	the	DET
ajlm-806	54	2	overall	overall	ADJ
ajlm-806	54	3	positive	positive	ADJ
ajlm-806	54	4	predictive	predictive	ADJ
ajlm-806	54	5	values	value	NOUN
ajlm-806	54	6	and	and	CCONJ
ajlm-806	54	7	negative	negative	ADJ
ajlm-806	54	8	predictive	predictive	ADJ
ajlm-806	54	9	values	value	NOUN
ajlm-806	54	10	for	for	ADP
ajlm-806	54	11	mdr	mdr	NOUN
ajlm-806	54	12	tuberculosis	tuberculosis	NOUN
ajlm-806	54	13	diagnosis	diagnosis	NOUN
ajlm-806	54	14	for	for	ADP
ajlm-806	54	15	xpert	xpert	PROPN
ajlm-806	54	16	mtb	mtb	PROPN
ajlm-806	54	17	/	/	SYM
ajlm-806	54	18	rif	rif	PROPN
ajlm-806	54	19	compared	compare	VERB
ajlm-806	54	20	to	to	ADP
ajlm-806	54	21	mgit	mgit	ADJ
ajlm-806	54	22	drug	drug	NOUN
ajlm-806	54	23	susceptibility	susceptibility	NOUN
ajlm-806	54	24	testing	testing	NOUN
ajlm-806	54	25	were	be	AUX
ajlm-806	54	26	62.5	62.5	NUM
ajlm-806	54	27	%	%	NOUN
ajlm-806	54	28	and	and	CCONJ
ajlm-806	54	29	100	100	NUM
ajlm-806	54	30	%	%	NOUN
ajlm-806	54	31	and	and	CCONJ
ajlm-806	54	32	compared	compare	VERB
ajlm-806	54	33	to	to	ADP
ajlm-806	54	34	mtbdrplus	mtbdrplus	ADJ
ajlm-806	54	35	were	be	AUX
ajlm-806	54	36	81.2	81.2	NUM
ajlm-806	54	37	%	%	NOUN
ajlm-806	54	38	and	and	CCONJ
ajlm-806	54	39	100	100	NUM
ajlm-806	54	40	%	%	NOUN
ajlm-806	54	41	(	(	PUNCT
ajlm-806	54	42	results	result	NOUN
ajlm-806	54	43	not	not	PART
ajlm-806	54	44	shown	show	VERB
ajlm-806	54	45	)	)	PUNCT
ajlm-806	54	46	.	.	PUNCT
ajlm-806	55	1	for	for	ADP
ajlm-806	55	2	previously	previously	ADV
ajlm-806	55	3	treated	treat	VERB
ajlm-806	55	4	patients	patient	NOUN
ajlm-806	55	5	,	,	PUNCT
ajlm-806	55	6	the	the	DET
ajlm-806	55	7	xpert	xpert	PROPN
ajlm-806	55	8	mtb	mtb	PROPN
ajlm-806	55	9	/	/	SYM
ajlm-806	55	10	rif	rif	PROPN
ajlm-806	55	11	positive	positive	ADJ
ajlm-806	55	12	predictive	predictive	ADJ
ajlm-806	55	13	value	value	NOUN
ajlm-806	55	14	was	be	AUX
ajlm-806	55	15	77.8	77.8	NUM
ajlm-806	55	16	%	%	NOUN
ajlm-806	55	17	and	and	CCONJ
ajlm-806	55	18	negative	negative	ADJ
ajlm-806	55	19	predictive	predictive	ADJ
ajlm-806	55	20	value	value	NOUN
ajlm-806	55	21	was	be	AUX
ajlm-806	55	22	100	100	NUM
ajlm-806	55	23	%	%	NOUN
ajlm-806	55	24	;	;	PUNCT
ajlm-806	55	25	for	for	ADP
ajlm-806	55	26	new	new	ADJ
ajlm-806	55	27	patients	patient	NOUN
ajlm-806	55	28	,	,	PUNCT
ajlm-806	55	29	positive	positive	ADJ
ajlm-806	55	30	predictive	predictive	ADJ
ajlm-806	55	31	value	value	NOUN
ajlm-806	55	32	was	be	AUX
ajlm-806	55	33	47.8	47.8	NUM
ajlm-806	55	34	%	%	NOUN
ajlm-806	55	35	and	and	CCONJ
ajlm-806	55	36	negative	negative	ADJ
ajlm-806	55	37	predictive	predictive	ADJ
ajlm-806	55	38	value	value	NOUN
ajlm-806	55	39	was	be	AUX
ajlm-806	55	40	100	100	NUM
ajlm-806	55	41	%	%	NOUN
ajlm-806	55	42	.	.	PUNCT
ajlm-806	56	1	the	the	DET
ajlm-806	56	2	mtbdrplus	mtbdrplus	ADJ
ajlm-806	56	3	positive	positive	ADJ
ajlm-806	56	4	predictive	predictive	ADJ
ajlm-806	56	5	value	value	NOUN
ajlm-806	56	6	was	be	AUX
ajlm-806	56	7	78.6	78.6	NUM
ajlm-806	56	8	%	%	NOUN
ajlm-806	56	9	and	and	CCONJ
ajlm-806	56	10	negative	negative	ADJ
ajlm-806	56	11	predictive	predictive	ADJ
ajlm-806	56	12	value	value	NOUN
ajlm-806	56	13	was	be	AUX
ajlm-806	56	14	100	100	NUM
ajlm-806	56	15	%	%	NOUN
ajlm-806	56	16	compared	compare	VERB
ajlm-806	56	17	to	to	ADP
ajlm-806	56	18	mgit	mgit	PROPN
ajlm-806	56	19	.	.	PUNCT
ajlm-806	57	1	discussion	discussion	NOUN
ajlm-806	57	2	indeterminate	indeterminate	VERB
ajlm-806	57	3	rifampicin	rifampicin	VERB
ajlm-806	57	4	resistance	resistance	NOUN
ajlm-806	57	5	results	result	NOUN
ajlm-806	57	6	can	can	AUX
ajlm-806	57	7	be	be	AUX
ajlm-806	57	8	resolved	resolve	VERB
ajlm-806	57	9	by	by	ADP
ajlm-806	57	10	repeating	repeat	VERB
ajlm-806	57	11	the	the	DET
ajlm-806	57	12	test	test	NOUN
ajlm-806	57	13	,	,	PUNCT
ajlm-806	57	14	as	as	SCONJ
ajlm-806	57	15	shown	show	VERB
ajlm-806	57	16	in	in	ADP
ajlm-806	57	17	our	our	PRON
ajlm-806	57	18	study	study	NOUN
ajlm-806	57	19	.	.	PUNCT
ajlm-806	58	1	of	of	ADP
ajlm-806	58	2	all	all	DET
ajlm-806	58	3	the	the	DET
ajlm-806	58	4	samples	sample	NOUN
ajlm-806	58	5	that	that	PRON
ajlm-806	58	6	were	be	AUX
ajlm-806	58	7	initially	initially	ADV
ajlm-806	58	8	indeterminate	indeterminate	ADJ
ajlm-806	58	9	for	for	ADP
ajlm-806	58	10	rifampicin	rifampicin	VERB
ajlm-806	58	11	resistance	resistance	NOUN
ajlm-806	58	12	,	,	PUNCT
ajlm-806	58	13	none	none	NOUN
ajlm-806	58	14	tested	test	VERB
ajlm-806	58	15	positive	positive	ADJ
ajlm-806	58	16	on	on	ADP
ajlm-806	58	17	repeat	repeat	NOUN
ajlm-806	58	18	testing	testing	NOUN
ajlm-806	58	19	.	.	PUNCT
ajlm-806	59	1	an	an	DET
ajlm-806	59	2	indeterminate	indeterminate	ADJ
ajlm-806	59	3	rifampicin	rifampicin	VERB
ajlm-806	59	4	resistance	resistance	NOUN
ajlm-806	59	5	xpert	xpert	PROPN
ajlm-806	59	6	mtb	mtb	PROPN
ajlm-806	59	7	/	/	SYM
ajlm-806	59	8	rif	rif	PROPN
ajlm-806	59	9	result	result	NOUN
ajlm-806	59	10	maybe	maybe	ADV
ajlm-806	59	11	due	due	ADJ
ajlm-806	59	12	to	to	ADP
ajlm-806	59	13	low	low	ADJ
ajlm-806	59	14	dna	dna	NOUN
ajlm-806	59	15	quantity	quantity	NOUN
ajlm-806	59	16	in	in	ADP
ajlm-806	59	17	the	the	DET
ajlm-806	59	18	sample	sample	NOUN
ajlm-806	59	19	;	;	PUNCT
ajlm-806	59	20	this	this	PRON
ajlm-806	59	21	was	be	AUX
ajlm-806	59	22	supported	support	VERB
ajlm-806	59	23	by	by	ADP
ajlm-806	59	24	the	the	DET
ajlm-806	59	25	high	high	ADJ
ajlm-806	59	26	proportion	proportion	NOUN
ajlm-806	59	27	of	of	ADP
ajlm-806	59	28	samples	sample	NOUN
ajlm-806	59	29	that	that	PRON
ajlm-806	59	30	were	be	AUX
ajlm-806	59	31	initially	initially	ADV
ajlm-806	59	32	indeterminate	indeterminate	ADJ
ajlm-806	59	33	that	that	PRON
ajlm-806	59	34	did	do	AUX
ajlm-806	59	35	not	not	PART
ajlm-806	59	36	detect	detect	VERB
ajlm-806	59	37	m.	m.	NOUN
ajlm-806	59	38	tuberculosis	tuberculosis	NOUN
ajlm-806	59	39	on	on	ADP
ajlm-806	59	40	repeat	repeat	NOUN
ajlm-806	59	41	testing	testing	NOUN
ajlm-806	59	42	with	with	ADP
ajlm-806	59	43	xpert	xpert	PROPN
ajlm-806	59	44	mtb	mtb	PROPN
ajlm-806	59	45	/	/	SYM
ajlm-806	59	46	rif	rif	PROPN
ajlm-806	59	47	but	but	CCONJ
ajlm-806	59	48	were	be	AUX
ajlm-806	59	49	positive	positive	ADJ
ajlm-806	59	50	on	on	ADP
ajlm-806	59	51	m.	m.	NOUN
ajlm-806	59	52	tuberculosis	tuberculosis	NOUN
ajlm-806	59	53	culture	culture	NOUN
ajlm-806	59	54	.	.	PUNCT
ajlm-806	60	1	for	for	ADP
ajlm-806	60	2	prediction	prediction	NOUN
ajlm-806	60	3	of	of	ADP
ajlm-806	60	4	mdr	mdr	PROPN
ajlm-806	60	5	tuberculosis	tuberculosis	NOUN
ajlm-806	60	6	,	,	PUNCT
ajlm-806	60	7	our	our	PRON
ajlm-806	60	8	findings	finding	NOUN
ajlm-806	60	9	confirm	confirm	VERB
ajlm-806	60	10	that	that	SCONJ
ajlm-806	60	11	xpert	xpert	PROPN
ajlm-806	60	12	mtb	mtb	PROPN
ajlm-806	60	13	/	/	SYM
ajlm-806	60	14	rif	rif	PROPN
ajlm-806	60	15	has	have	VERB
ajlm-806	60	16	a	a	DET
ajlm-806	60	17	low	low	ADJ
ajlm-806	60	18	positive	positive	ADJ
ajlm-806	60	19	predictive	predictive	ADJ
ajlm-806	60	20	value	value	NOUN
ajlm-806	60	21	for	for	ADP
ajlm-806	60	22	mdr	mdr	PROPN
ajlm-806	60	23	tuberculosis	tuberculosis	NOUN
ajlm-806	60	24	in	in	ADP
ajlm-806	60	25	low	low	ADJ
ajlm-806	60	26	-	-	PUNCT
ajlm-806	60	27	prevalence	prevalence	NOUN
ajlm-806	60	28	mdr	mdr	NOUN
ajlm-806	61	1	tuberculosis	tuberculosis	NOUN
ajlm-806	61	2	settings	setting	NOUN
ajlm-806	61	3	like	like	ADP
ajlm-806	61	4	zambia	zambia	PROPN
ajlm-806	61	5	,	,	PUNCT
ajlm-806	61	6	which	which	PRON
ajlm-806	61	7	has	have	VERB
ajlm-806	61	8	an	an	DET
ajlm-806	61	9	estimated	estimate	VERB
ajlm-806	61	10	mdr	mdr	NOUN
ajlm-806	61	11	prevalence	prevalence	NOUN
ajlm-806	61	12	of	of	ADP
ajlm-806	61	13	4.2%.10	4.2%.10	PRON
ajlm-806	61	14	depending	depend	VERB
ajlm-806	61	15	on	on	ADP
ajlm-806	61	16	xpert	xpert	PROPN
ajlm-806	61	17	mtb	mtb	PROPN
ajlm-806	61	18	/	/	SYM
ajlm-806	61	19	rif	rif	PROPN
ajlm-806	61	20	alone	alone	ADV
ajlm-806	61	21	for	for	ADP
ajlm-806	61	22	diagnosis	diagnosis	NOUN
ajlm-806	61	23	of	of	ADP
ajlm-806	61	24	mdr	mdr	PROPN
ajlm-806	61	25	tuberculosis	tuberculosis	NOUN
ajlm-806	61	26	in	in	ADP
ajlm-806	61	27	our	our	PRON
ajlm-806	61	28	setting	setting	NOUN
ajlm-806	61	29	would	would	AUX
ajlm-806	61	30	lead	lead	VERB
ajlm-806	61	31	to	to	ADP
ajlm-806	61	32	subjecting	subject	VERB
ajlm-806	61	33	a	a	DET
ajlm-806	61	34	significant	significant	ADJ
ajlm-806	61	35	proportion	proportion	NOUN
ajlm-806	61	36	of	of	ADP
ajlm-806	61	37	patients	patient	NOUN
ajlm-806	61	38	to	to	PART
ajlm-806	61	39	unnecessary	unnecessary	ADJ
ajlm-806	61	40	second	second	ADJ
ajlm-806	61	41	-	-	PUNCT
ajlm-806	61	42	line	line	NOUN
ajlm-806	61	43	treatment.1	treatment.1	NOUN
ajlm-806	61	44	the	the	DET
ajlm-806	61	45	performance	performance	NOUN
ajlm-806	61	46	of	of	ADP
ajlm-806	61	47	xpert	xpert	PROPN
ajlm-806	61	48	mtb	mtb	PROPN
ajlm-806	61	49	/	/	SYM
ajlm-806	61	50	rif	rif	PROPN
ajlm-806	61	51	and	and	CCONJ
ajlm-806	61	52	mtbdrplus	mtbdrplus	ADJ
ajlm-806	61	53	were	be	AUX
ajlm-806	61	54	similar	similar	ADJ
ajlm-806	61	55	,	,	PUNCT
ajlm-806	61	56	which	which	PRON
ajlm-806	61	57	was	be	AUX
ajlm-806	61	58	expected	expect	VERB
ajlm-806	61	59	since	since	SCONJ
ajlm-806	61	60	both	both	PRON
ajlm-806	61	61	are	be	AUX
ajlm-806	61	62	genotypic	genotypic	NOUN
ajlm-806	61	63	tests	test	NOUN
ajlm-806	61	64	.	.	PUNCT
ajlm-806	62	1	the	the	DET
ajlm-806	62	2	sensitivity	sensitivity	NOUN
ajlm-806	62	3	of	of	ADP
ajlm-806	62	4	xpert	xpert	PROPN
ajlm-806	62	5	mtb	mtb	PROPN
ajlm-806	62	6	/	/	SYM
ajlm-806	62	7	rif	rif	PROPN
ajlm-806	62	8	for	for	ADP
ajlm-806	62	9	detection	detection	NOUN
ajlm-806	62	10	of	of	ADP
ajlm-806	62	11	rifampicin	rifampicin	VERB
ajlm-806	62	12	resistance	resistance	NOUN
ajlm-806	62	13	was	be	AUX
ajlm-806	62	14	within	within	ADP
ajlm-806	62	15	the	the	DET
ajlm-806	62	16	range	range	NOUN
ajlm-806	62	17	of	of	ADP
ajlm-806	62	18	what	what	PRON
ajlm-806	62	19	has	have	AUX
ajlm-806	62	20	been	be	AUX
ajlm-806	62	21	reported	report	VERB
ajlm-806	62	22	by	by	ADP
ajlm-806	62	23	others	other	NOUN
ajlm-806	62	24	,	,	PUNCT
ajlm-806	62	25	whereas	whereas	SCONJ
ajlm-806	62	26	the	the	DET
ajlm-806	62	27	specificity	specificity	NOUN
ajlm-806	62	28	of	of	ADP
ajlm-806	62	29	73	73	NUM
ajlm-806	62	30	%	%	NOUN
ajlm-806	62	31	was	be	AUX
ajlm-806	62	32	lower.11	lower.11	VERB
ajlm-806	62	33	the	the	DET
ajlm-806	62	34	prevalence	prevalence	NOUN
ajlm-806	62	35	of	of	ADP
ajlm-806	62	36	silent	silent	ADJ
ajlm-806	62	37	rpob	rpob	PROPN
ajlm-806	62	38	gene	gene	NOUN
ajlm-806	62	39	mutations	mutation	NOUN
ajlm-806	62	40	that	that	PRON
ajlm-806	62	41	do	do	AUX
ajlm-806	62	42	not	not	PART
ajlm-806	62	43	confer	confer	VERB
ajlm-806	62	44	phenotypic	phenotypic	ADJ
ajlm-806	62	45	resistance	resistance	NOUN
ajlm-806	62	46	determines	determine	VERB
ajlm-806	62	47	the	the	DET
ajlm-806	62	48	specificity	specificity	NOUN
ajlm-806	62	49	of	of	ADP
ajlm-806	62	50	genotypic	genotypic	ADJ
ajlm-806	62	51	tests	test	NOUN
ajlm-806	62	52	,	,	PUNCT
ajlm-806	62	53	if	if	SCONJ
ajlm-806	62	54	using	use	VERB
ajlm-806	62	55	a	a	DET
ajlm-806	62	56	phenotypic	phenotypic	ADJ
ajlm-806	62	57	test	test	NOUN
ajlm-806	62	58	as	as	ADP
ajlm-806	62	59	a	a	DET
ajlm-806	62	60	gold	gold	NOUN
ajlm-806	62	61	standard	standard	NOUN
ajlm-806	62	62	.	.	PUNCT
ajlm-806	63	1	while	while	SCONJ
ajlm-806	63	2	we	we	PRON
ajlm-806	63	3	were	be	AUX
ajlm-806	63	4	limited	limit	VERB
ajlm-806	63	5	by	by	ADP
ajlm-806	63	6	a	a	DET
ajlm-806	63	7	lack	lack	NOUN
ajlm-806	63	8	of	of	ADP
ajlm-806	63	9	capacity	capacity	NOUN
ajlm-806	63	10	to	to	PART
ajlm-806	63	11	sequence	sequence	VERB
ajlm-806	63	12	the	the	DET
ajlm-806	63	13	three	three	NUM
ajlm-806	63	14	samples	sample	NOUN
ajlm-806	63	15	that	that	PRON
ajlm-806	63	16	had	have	VERB
ajlm-806	63	17	results	result	NOUN
ajlm-806	63	18	suggesting	suggest	VERB
ajlm-806	63	19	false	false	ADJ
ajlm-806	63	20	rifampicin	rifampicin	VERB
ajlm-806	63	21	resistance	resistance	NOUN
ajlm-806	63	22	,	,	PUNCT
ajlm-806	63	23	other	other	ADJ
ajlm-806	63	24	studies	study	NOUN
ajlm-806	63	25	have	have	AUX
ajlm-806	63	26	reported	report	VERB
ajlm-806	63	27	false	false	ADJ
ajlm-806	63	28	xpert	xpert	PROPN
ajlm-806	63	29	mtb	mtb	PROPN
ajlm-806	63	30	/	/	SYM
ajlm-806	63	31	rif	rif	PROPN
ajlm-806	63	32	or	or	CCONJ
ajlm-806	63	33	mtbdrplus	mtbdrplus	ADJ
ajlm-806	63	34	rifampicin	rifampicin	VERB
ajlm-806	63	35	resistance	resistance	NOUN
ajlm-806	63	36	caused	cause	VERB
ajlm-806	63	37	by	by	ADP
ajlm-806	63	38	silent	silent	ADJ
ajlm-806	63	39	mutations	mutation	NOUN
ajlm-806	63	40	in	in	ADP
ajlm-806	63	41	the	the	DET
ajlm-806	63	42	rpob	rpob	PROPN
ajlm-806	63	43	gene.12,13,14,15,16	gene.12,13,14,15,16	PROPN
ajlm-806	63	44	further	far	ADV
ajlm-806	63	45	,	,	PUNCT
ajlm-806	63	46	these	these	DET
ajlm-806	63	47	three	three	NUM
ajlm-806	63	48	isolates	isolate	NOUN
ajlm-806	63	49	were	be	AUX
ajlm-806	63	50	also	also	ADV
ajlm-806	63	51	resistant	resistant	ADJ
ajlm-806	63	52	to	to	ADP
ajlm-806	63	53	isoniazid	isoniazid	NOUN
ajlm-806	63	54	on	on	ADP
ajlm-806	63	55	both	both	DET
ajlm-806	63	56	mgit	mgit	ADJ
ajlm-806	63	57	drug	drug	NOUN
ajlm-806	63	58	susceptibility	susceptibility	NOUN
ajlm-806	63	59	testing	testing	NOUN
ajlm-806	63	60	and	and	CCONJ
ajlm-806	63	61	mtbdrplus	mtbdrplus	ADJ
ajlm-806	63	62	,	,	PUNCT
ajlm-806	63	63	consistent	consistent	ADJ
ajlm-806	63	64	with	with	ADP
ajlm-806	63	65	the	the	DET
ajlm-806	63	66	widely	widely	ADV
ajlm-806	63	67	observed	observe	VERB
ajlm-806	63	68	fact	fact	NOUN
ajlm-806	63	69	that	that	SCONJ
ajlm-806	63	70	in	in	ADP
ajlm-806	63	71	most	most	ADJ
ajlm-806	63	72	cases	case	NOUN
ajlm-806	63	73	,	,	PUNCT
ajlm-806	63	74	silent	silent	ADJ
ajlm-806	63	75	mutations	mutation	NOUN
ajlm-806	63	76	in	in	ADP
ajlm-806	63	77	the	the	DET
ajlm-806	63	78	rpob	rpob	PROPN
ajlm-806	63	79	gene	gene	NOUN
ajlm-806	63	80	are	be	AUX
ajlm-806	63	81	associated	associate	VERB
ajlm-806	63	82	with	with	ADP
ajlm-806	63	83	mutations	mutation	NOUN
ajlm-806	63	84	in	in	ADP
ajlm-806	63	85	the	the	DET
ajlm-806	63	86	katg	katg	PROPN
ajlm-806	63	87	gene	gene	NOUN
ajlm-806	63	88	or	or	CCONJ
ajlm-806	63	89	promoter	promoter	NOUN
ajlm-806	63	90	of	of	ADP
ajlm-806	63	91	the	the	DET
ajlm-806	63	92	inha	inha	NOUN
ajlm-806	63	93	gene.17,18	gene.17,18	ADJ
ajlm-806	63	94	probe	probe	NOUN
ajlm-806	64	1	d	d	NOUN
ajlm-806	64	2	in	in	ADP
ajlm-806	64	3	the	the	DET
ajlm-806	64	4	xpert	xpert	PROPN
ajlm-806	64	5	mtb	mtb	PROPN
ajlm-806	64	6	/	/	SYM
ajlm-806	64	7	rif	rif	PROPN
ajlm-806	64	8	and	and	CCONJ
ajlm-806	64	9	the	the	DET
ajlm-806	64	10	wild	wild	ADJ
ajlm-806	64	11	-	-	PUNCT
ajlm-806	64	12	type	type	NOUN
ajlm-806	64	13	7	7	NUM
ajlm-806	64	14	probe	probe	NOUN
ajlm-806	64	15	in	in	ADP
ajlm-806	64	16	mtbdrplus	mtbdrplus	ADJ
ajlm-806	64	17	both	both	PRON
ajlm-806	64	18	target	target	VERB
ajlm-806	64	19	the	the	DET
ajlm-806	64	20	same	same	ADJ
ajlm-806	64	21	region	region	NOUN
ajlm-806	64	22	of	of	ADP
ajlm-806	64	23	the	the	DET
ajlm-806	64	24	rpob	rpob	PROPN
ajlm-806	64	25	gene	gene	NOUN
ajlm-806	64	26	,	,	PUNCT
ajlm-806	64	27	codon	codon	NOUN
ajlm-806	64	28	526	526	NUM
ajlm-806	64	29	,	,	PUNCT
ajlm-806	64	30	which	which	PRON
ajlm-806	64	31	is	be	AUX
ajlm-806	64	32	one	one	NUM
ajlm-806	64	33	of	of	ADP
ajlm-806	64	34	the	the	DET
ajlm-806	64	35	regions	region	NOUN
ajlm-806	64	36	with	with	ADP
ajlm-806	64	37	known	know	VERB
ajlm-806	64	38	mutations	mutation	NOUN
ajlm-806	64	39	that	that	PRON
ajlm-806	64	40	confer	confer	VERB
ajlm-806	64	41	resistance	resistance	NOUN
ajlm-806	64	42	to	to	ADP
ajlm-806	64	43	rifampicin	rifampicin	VERB
ajlm-806	64	44	.	.	PUNCT
ajlm-806	65	1	detection	detection	NOUN
ajlm-806	65	2	of	of	ADP
ajlm-806	65	3	mutations	mutation	NOUN
ajlm-806	65	4	in	in	ADP
ajlm-806	65	5	this	this	DET
ajlm-806	65	6	region	region	NOUN
ajlm-806	65	7	by	by	ADP
ajlm-806	65	8	both	both	DET
ajlm-806	65	9	xpert	xpert	PROPN
ajlm-806	65	10	mtb	mtb	PROPN
ajlm-806	65	11	/	/	SYM
ajlm-806	65	12	rif	rif	PROPN
ajlm-806	65	13	and	and	CCONJ
ajlm-806	65	14	mtbdrplus	mtbdrplus	ADJ
ajlm-806	65	15	shows	show	VERB
ajlm-806	65	16	strong	strong	ADJ
ajlm-806	65	17	evidence	evidence	NOUN
ajlm-806	65	18	of	of	ADP
ajlm-806	65	19	the	the	DET
ajlm-806	65	20	accuracy	accuracy	NOUN
ajlm-806	65	21	of	of	ADP
ajlm-806	65	22	our	our	PRON
ajlm-806	65	23	genotypic	genotypic	NOUN
ajlm-806	65	24	results	result	NOUN
ajlm-806	65	25	.	.	PUNCT
ajlm-806	66	1	however	however	ADV
ajlm-806	66	2	,	,	PUNCT
ajlm-806	66	3	mgit	mgit	ADJ
ajlm-806	66	4	drug	drug	NOUN
ajlm-806	66	5	susceptibility	susceptibility	NOUN
ajlm-806	66	6	testing	testing	NOUN
ajlm-806	66	7	has	have	AUX
ajlm-806	66	8	been	be	AUX
ajlm-806	66	9	shown	show	VERB
ajlm-806	66	10	to	to	PART
ajlm-806	66	11	produce	produce	VERB
ajlm-806	66	12	false	false	ADJ
ajlm-806	66	13	susceptibility	susceptibility	NOUN
ajlm-806	66	14	results	result	NOUN
ajlm-806	66	15	for	for	ADP
ajlm-806	66	16	strains	strain	NOUN
ajlm-806	66	17	with	with	ADP
ajlm-806	66	18	minimal	minimal	ADJ
ajlm-806	66	19	inhibitory	inhibitory	ADJ
ajlm-806	66	20	concentrations	concentration	NOUN
ajlm-806	66	21	for	for	ADP
ajlm-806	66	22	rifampicin	rifampicin	VERB
ajlm-806	66	23	close	close	ADV
ajlm-806	66	24	to	to	ADP
ajlm-806	66	25	the	the	DET
ajlm-806	66	26	cut	cut	VERB
ajlm-806	66	27	-	-	PUNCT
ajlm-806	66	28	off	off	ADP
ajlm-806	66	29	value	value	NOUN
ajlm-806	66	30	of	of	ADP
ajlm-806	66	31	1	1	NUM
ajlm-806	66	32	µg	µg	ADV
ajlm-806	66	33	/	/	SYM
ajlm-806	66	34	ml	ml	NOUN
ajlm-806	66	35	used	use	VERB
ajlm-806	66	36	in	in	ADP
ajlm-806	66	37	mgit	mgit	ADJ
ajlm-806	66	38	drug	drug	NOUN
ajlm-806	66	39	susceptibility	susceptibility	NOUN
ajlm-806	66	40	testing	testing	NOUN
ajlm-806	66	41	,	,	PUNCT
ajlm-806	66	42	or	or	CCONJ
ajlm-806	66	43	strains	strain	NOUN
ajlm-806	66	44	that	that	PRON
ajlm-806	66	45	have	have	VERB
ajlm-806	66	46	sub	sub	ADJ
ajlm-806	66	47	-	-	ADJ
ajlm-806	66	48	critical	critical	ADJ
ajlm-806	66	49	minimal	minimal	ADJ
ajlm-806	66	50	inhibitory	inhibitory	ADJ
ajlm-806	66	51	concentrations	concentration	NOUN
ajlm-806	66	52	for	for	ADP
ajlm-806	66	53	rifampicin.19	rifampicin.19	NOUN
ajlm-806	66	54	however	however	ADV
ajlm-806	66	55	,	,	PUNCT
ajlm-806	66	56	it	it	PRON
ajlm-806	66	57	is	be	AUX
ajlm-806	66	58	unlikely	unlikely	ADJ
ajlm-806	66	59	that	that	SCONJ
ajlm-806	66	60	the	the	DET
ajlm-806	66	61	discordant	discordant	ADJ
ajlm-806	66	62	results	result	NOUN
ajlm-806	66	63	in	in	ADP
ajlm-806	66	64	our	our	PRON
ajlm-806	66	65	study	study	NOUN
ajlm-806	66	66	were	be	AUX
ajlm-806	66	67	due	due	ADJ
ajlm-806	66	68	to	to	ADP
ajlm-806	66	69	false	false	ADJ
ajlm-806	66	70	susceptibility	susceptibility	NOUN
ajlm-806	66	71	results	result	NOUN
ajlm-806	66	72	for	for	ADP
ajlm-806	66	73	the	the	DET
ajlm-806	66	74	mgit	mgit	ADJ
ajlm-806	66	75	drug	drug	NOUN
ajlm-806	66	76	susceptibility	susceptibility	NOUN
ajlm-806	66	77	testing	testing	NOUN
ajlm-806	66	78	.	.	PUNCT
ajlm-806	67	1	to	to	PART
ajlm-806	67	2	resolve	resolve	VERB
ajlm-806	67	3	these	these	DET
ajlm-806	67	4	discrepant	discrepant	NOUN
ajlm-806	67	5	results	result	NOUN
ajlm-806	67	6	,	,	PUNCT
ajlm-806	67	7	sequencing	sequencing	NOUN
ajlm-806	67	8	is	be	AUX
ajlm-806	67	9	required	require	VERB
ajlm-806	67	10	to	to	PART
ajlm-806	67	11	determine	determine	VERB
ajlm-806	67	12	the	the	DET
ajlm-806	67	13	presence	presence	NOUN
ajlm-806	67	14	of	of	ADP
ajlm-806	67	15	silent	silent	ADJ
ajlm-806	67	16	mutations	mutation	NOUN
ajlm-806	67	17	.	.	PUNCT
ajlm-806	68	1	however	however	ADV
ajlm-806	68	2	,	,	PUNCT
ajlm-806	68	3	lack	lack	NOUN
ajlm-806	68	4	of	of	ADP
ajlm-806	68	5	access	access	NOUN
ajlm-806	68	6	to	to	ADP
ajlm-806	68	7	sequencing	sequence	VERB
ajlm-806	68	8	services	service	NOUN
ajlm-806	68	9	was	be	AUX
ajlm-806	68	10	a	a	DET
ajlm-806	68	11	limitation	limitation	NOUN
ajlm-806	68	12	in	in	ADP
ajlm-806	68	13	our	our	PRON
ajlm-806	68	14	study	study	NOUN
ajlm-806	68	15	.	.	PUNCT
ajlm-806	69	1	this	this	DET
ajlm-806	69	2	study	study	NOUN
ajlm-806	69	3	was	be	AUX
ajlm-806	69	4	also	also	ADV
ajlm-806	69	5	limited	limit	VERB
ajlm-806	69	6	by	by	ADP
ajlm-806	69	7	its	its	PRON
ajlm-806	69	8	small	small	ADJ
ajlm-806	69	9	sample	sample	NOUN
ajlm-806	69	10	size	size	NOUN
ajlm-806	69	11	but	but	CCONJ
ajlm-806	69	12	provides	provide	VERB
ajlm-806	69	13	some	some	DET
ajlm-806	69	14	insights	insight	NOUN
ajlm-806	69	15	into	into	ADP
ajlm-806	69	16	the	the	DET
ajlm-806	69	17	comparable	comparable	ADJ
ajlm-806	69	18	performance	performance	NOUN
ajlm-806	69	19	of	of	ADP
ajlm-806	69	20	xpert	xpert	PROPN
ajlm-806	69	21	mtb	mtb	PROPN
ajlm-806	69	22	/	/	SYM
ajlm-806	69	23	rif	rif	PROPN
ajlm-806	69	24	,	,	PUNCT
ajlm-806	69	25	mtbdrplus	mtbdrplus	ADJ
ajlm-806	69	26	and	and	CCONJ
ajlm-806	69	27	culture	culture	NOUN
ajlm-806	69	28	drug	drug	NOUN
ajlm-806	69	29	susceptibility	susceptibility	NOUN
ajlm-806	69	30	testing	test	VERB
ajlm-806	69	31	culture	culture	NOUN
ajlm-806	69	32	for	for	ADP
ajlm-806	69	33	the	the	DET
ajlm-806	69	34	diagnosis	diagnosis	NOUN
ajlm-806	69	35	of	of	ADP
ajlm-806	69	36	drug	drug	NOUN
ajlm-806	69	37	-	-	PUNCT
ajlm-806	69	38	resistant	resistant	ADJ
ajlm-806	69	39	tuberculosis	tuberculosis	NOUN
ajlm-806	69	40	.	.	PUNCT
ajlm-806	70	1	there	there	PRON
ajlm-806	70	2	is	be	VERB
ajlm-806	70	3	an	an	DET
ajlm-806	70	4	urgent	urgent	ADJ
ajlm-806	70	5	need	need	NOUN
ajlm-806	70	6	for	for	SCONJ
ajlm-806	70	7	zambia	zambia	PROPN
ajlm-806	70	8	to	to	PART
ajlm-806	70	9	perform	perform	VERB
ajlm-806	70	10	a	a	DET
ajlm-806	70	11	full	full	ADJ
ajlm-806	70	12	identification	identification	NOUN
ajlm-806	70	13	and	and	CCONJ
ajlm-806	70	14	classification	classification	NOUN
ajlm-806	70	15	of	of	ADP
ajlm-806	70	16	rpob	rpob	ADJ
ajlm-806	70	17	mutations	mutation	NOUN
ajlm-806	70	18	and	and	CCONJ
ajlm-806	70	19	investigate	investigate	VERB
ajlm-806	70	20	minimal	minimal	ADJ
ajlm-806	70	21	inhibitory	inhibitory	ADJ
ajlm-806	70	22	concentrations	concentration	NOUN
ajlm-806	70	23	for	for	ADP
ajlm-806	70	24	rifampicin	rifampicin	VERB
ajlm-806	70	25	,	,	PUNCT
ajlm-806	70	26	so	so	SCONJ
ajlm-806	70	27	as	as	SCONJ
ajlm-806	70	28	to	to	PART
ajlm-806	70	29	optimise	optimise	VERB
ajlm-806	70	30	national	national	ADJ
ajlm-806	70	31	guidelines	guideline	NOUN
ajlm-806	70	32	for	for	ADP
ajlm-806	70	33	diagnosis	diagnosis	NOUN
ajlm-806	70	34	of	of	ADP
ajlm-806	70	35	drug	drug	NOUN
ajlm-806	70	36	-	-	PUNCT
ajlm-806	70	37	resistant	resistant	ADJ
ajlm-806	70	38	tuberculosis	tuberculosis	NOUN
ajlm-806	70	39	.	.	PUNCT
ajlm-806	71	1	a	a	DET
ajlm-806	71	2	thorough	thorough	ADJ
ajlm-806	71	3	investigation	investigation	NOUN
ajlm-806	71	4	of	of	ADP
ajlm-806	71	5	the	the	DET
ajlm-806	71	6	performance	performance	NOUN
ajlm-806	71	7	of	of	ADP
ajlm-806	71	8	xpert	xpert	PROPN
ajlm-806	71	9	mtb	mtb	PROPN
ajlm-806	71	10	/	/	SYM
ajlm-806	71	11	rif	rif	PROPN
ajlm-806	71	12	and	and	CCONJ
ajlm-806	71	13	mtbdrplus	mtbdrplus	ADJ
ajlm-806	71	14	for	for	ADP
ajlm-806	71	15	diagnosis	diagnosis	NOUN
ajlm-806	71	16	of	of	ADP
ajlm-806	71	17	rifampicin	rifampicin	VERB
ajlm-806	71	18	resistance	resistance	NOUN
ajlm-806	71	19	and	and	CCONJ
ajlm-806	71	20	prediction	prediction	NOUN
ajlm-806	71	21	of	of	ADP
ajlm-806	71	22	mdr	mdr	PROPN
ajlm-806	71	23	tuberculosis	tuberculosis	NOUN
ajlm-806	71	24	in	in	ADP
ajlm-806	71	25	the	the	DET
ajlm-806	71	26	zambian	zambian	ADJ
ajlm-806	71	27	setting	setting	NOUN
ajlm-806	71	28	is	be	AUX
ajlm-806	71	29	recommended	recommend	VERB
ajlm-806	71	30	to	to	PART
ajlm-806	71	31	avoid	avoid	VERB
ajlm-806	71	32	inappropriate	inappropriate	ADJ
ajlm-806	71	33	treatment	treatment	NOUN
ajlm-806	71	34	.	.	PUNCT
ajlm-806	72	1	whole	whole	ADJ
ajlm-806	72	2	genome	genome	NOUN
ajlm-806	72	3	sequencing	sequencing	NOUN
ajlm-806	72	4	capacity	capacity	NOUN
ajlm-806	72	5	is	be	AUX
ajlm-806	72	6	required	require	VERB
ajlm-806	72	7	to	to	PART
ajlm-806	72	8	fully	fully	ADV
ajlm-806	72	9	characterise	characterise	VERB
ajlm-806	72	10	circulating	circulate	VERB
ajlm-806	72	11	rifampicin	rifampicin	VERB
ajlm-806	72	12	-	-	PUNCT
ajlm-806	72	13	resistant	resistant	ADJ
ajlm-806	72	14	m.	m.	NOUN
ajlm-806	72	15	tuberculosis	tuberculosis	NOUN
ajlm-806	72	16	strains	strain	NOUN
ajlm-806	72	17	.	.	PUNCT
ajlm-806	73	1	improvements	improvement	NOUN
ajlm-806	73	2	are	be	AUX
ajlm-806	73	3	needed	need	VERB
ajlm-806	73	4	to	to	PART
ajlm-806	73	5	make	make	VERB
ajlm-806	73	6	these	these	DET
ajlm-806	73	7	genotypic	genotypic	NOUN
ajlm-806	73	8	tests	test	NOUN
ajlm-806	73	9	function	function	VERB
ajlm-806	73	10	as	as	ADP
ajlm-806	73	11	stand	stand	VERB
ajlm-806	73	12	-	-	PUNCT
ajlm-806	73	13	alone	alone	ADV
ajlm-806	73	14	tests	test	NOUN
ajlm-806	73	15	,	,	PUNCT
ajlm-806	73	16	as	as	SCONJ
ajlm-806	73	17	they	they	PRON
ajlm-806	73	18	offer	offer	VERB
ajlm-806	73	19	the	the	DET
ajlm-806	73	20	best	good	ADJ
ajlm-806	73	21	prospects	prospect	NOUN
ajlm-806	73	22	for	for	ADP
ajlm-806	73	23	early	early	ADJ
ajlm-806	73	24	and	and	CCONJ
ajlm-806	73	25	accurate	accurate	ADJ
ajlm-806	73	26	diagnosis	diagnosis	NOUN
ajlm-806	73	27	for	for	ADP
ajlm-806	73	28	tuberculosis	tuberculosis	NOUN
ajlm-806	73	29	and	and	CCONJ
ajlm-806	73	30	mdr	mdr	PROPN
ajlm-806	73	31	tuberculosis	tuberculosis	NOUN
ajlm-806	73	32	.	.	PUNCT
ajlm-806	74	1	acknowledgements	acknowledgement	NOUN
ajlm-806	74	2	the	the	DET
ajlm-806	74	3	authors	author	NOUN
ajlm-806	74	4	would	would	AUX
ajlm-806	74	5	like	like	VERB
ajlm-806	74	6	to	to	PART
ajlm-806	74	7	acknowledge	acknowledge	VERB
ajlm-806	74	8	the	the	DET
ajlm-806	74	9	ministry	ministry	PROPN
ajlm-806	74	10	of	of	ADP
ajlm-806	74	11	health	health	PROPN
ajlm-806	74	12	of	of	ADP
ajlm-806	74	13	zambia	zambia	PROPN
ajlm-806	74	14	for	for	ADP
ajlm-806	74	15	permission	permission	NOUN
ajlm-806	74	16	to	to	PART
ajlm-806	74	17	conduct	conduct	VERB
ajlm-806	74	18	the	the	DET
ajlm-806	74	19	study	study	NOUN
ajlm-806	74	20	and	and	CCONJ
ajlm-806	74	21	lusaka	lusaka	PROPN
ajlm-806	74	22	district	district	PROPN
ajlm-806	74	23	health	health	NOUN
ajlm-806	74	24	staff	staff	NOUN
ajlm-806	74	25	at	at	ADP
ajlm-806	74	26	the	the	DET
ajlm-806	74	27	facilities	facility	NOUN
ajlm-806	74	28	where	where	SCONJ
ajlm-806	74	29	this	this	DET
ajlm-806	74	30	study	study	NOUN
ajlm-806	74	31	was	be	AUX
ajlm-806	74	32	conducted	conduct	VERB
ajlm-806	74	33	.	.	PUNCT
ajlm-806	75	1	competing	compete	VERB
ajlm-806	75	2	interests	interest	NOUN
ajlm-806	75	3	the	the	DET
ajlm-806	75	4	authors	author	NOUN
ajlm-806	75	5	declare	declare	VERB
ajlm-806	75	6	that	that	SCONJ
ajlm-806	75	7	they	they	PRON
ajlm-806	75	8	have	have	VERB
ajlm-806	75	9	no	no	DET
ajlm-806	75	10	financial	financial	ADJ
ajlm-806	75	11	or	or	CCONJ
ajlm-806	75	12	personal	personal	ADJ
ajlm-806	75	13	relationships	relationship	NOUN
ajlm-806	75	14	which	which	PRON
ajlm-806	75	15	may	may	AUX
ajlm-806	75	16	have	have	AUX
ajlm-806	75	17	inappropriately	inappropriately	ADV
ajlm-806	75	18	influenced	influence	VERB
ajlm-806	75	19	them	they	PRON
ajlm-806	75	20	in	in	ADP
ajlm-806	75	21	writing	write	VERB
ajlm-806	75	22	this	this	DET
ajlm-806	75	23	article	article	NOUN
ajlm-806	75	24	.	.	PUNCT
ajlm-806	76	1	sources	source	NOUN
ajlm-806	76	2	of	of	ADP
ajlm-806	76	3	support	support	NOUN
ajlm-806	76	4	this	this	DET
ajlm-806	76	5	study	study	NOUN
ajlm-806	76	6	was	be	AUX
ajlm-806	76	7	a	a	DET
ajlm-806	76	8	sub	sub	NOUN
ajlm-806	76	9	-	-	NOUN
ajlm-806	76	10	study	study	NOUN
ajlm-806	76	11	of	of	ADP
ajlm-806	76	12	the	the	DET
ajlm-806	76	13	xpert	xpert	PROPN
ajlm-806	76	14	evaluation	evaluation	NOUN
ajlm-806	76	15	study	study	NOUN
ajlm-806	76	16	funded	fund	VERB
ajlm-806	76	17	by	by	ADP
ajlm-806	76	18	the	the	DET
ajlm-806	76	19	stop	stop	NOUN
ajlm-806	76	20	tb	tb	ADP
ajlm-806	76	21	partnership	partnership	NOUN
ajlm-806	76	22	/	/	SYM
ajlm-806	76	23	tb	tb	NOUN
ajlm-806	76	24	reach	reach	NOUN
ajlm-806	76	25	wave	wave	NOUN
ajlm-806	76	26	2	2	NUM
ajlm-806	76	27	:	:	PUNCT
ajlm-806	76	28	t9	t9	PROPN
ajlm-806	76	29	-	-	PUNCT
ajlm-806	76	30	370	370	NUM
ajlm-806	76	31	-	-	SYM
ajlm-806	76	32	114	114	NUM
ajlm-806	76	33	.	.	PUNCT
ajlm-806	77	1	authors	author	NOUN
ajlm-806	77	2	’	’	PART
ajlm-806	77	3	contributions	contribution	NOUN
ajlm-806	77	4	m.m	m.m	PROPN
ajlm-806	77	5	.	.	PROPN
ajlm-806	77	6	and	and	CCONJ
ajlm-806	77	7	h.a	h.a	PROPN
ajlm-806	77	8	.	.	PROPN
ajlm-806	77	9	conceptualised	conceptualise	VERB
ajlm-806	77	10	the	the	DET
ajlm-806	77	11	study	study	NOUN
ajlm-806	77	12	.	.	PUNCT
ajlm-806	78	1	d.m	d.m	PROPN
ajlm-806	78	2	.	.	PROPN
ajlm-806	79	1	and	and	CCONJ
ajlm-806	79	2	n.k	n.k	PROPN
ajlm-806	79	3	.	.	PROPN
ajlm-806	79	4	designed	design	VERB
ajlm-806	79	5	the	the	DET
ajlm-806	79	6	databases	database	NOUN
ajlm-806	79	7	.	.	PUNCT
ajlm-806	80	1	m.c.l	m.c.l	PROPN
ajlm-806	80	2	.	.	PUNCT
ajlm-806	80	3	,	,	PUNCT
ajlm-806	80	4	m.m.c	m.m.c	PROPN
ajlm-806	80	5	.	.	PROPN
ajlm-806	80	6	,	,	PUNCT
ajlm-806	80	7	s.m	s.m	PROPN
ajlm-806	80	8	.	.	PROPN
ajlm-806	80	9	,	,	PUNCT
ajlm-806	80	10	m.m	m.m	PROPN
ajlm-806	80	11	.	.	PROPN
ajlm-806	80	12	,	,	PUNCT
ajlm-806	80	13	d.m	d.m	PROPN
ajlm-806	80	14	.	.	PROPN
ajlm-806	81	1	and	and	CCONJ
ajlm-806	81	2	w.m	w.m	PROPN
ajlm-806	81	3	.	.	PROPN
ajlm-806	81	4	performed	perform	VERB
ajlm-806	81	5	the	the	DET
ajlm-806	81	6	experiments	experiment	NOUN
ajlm-806	81	7	.	.	PUNCT
ajlm-806	82	1	m.m	m.m	PROPN
ajlm-806	82	2	.	.	PROPN
ajlm-806	82	3	analysed	analyse	VERB
ajlm-806	82	4	the	the	DET
ajlm-806	82	5	data	datum	NOUN
ajlm-806	82	6	.	.	PUNCT
ajlm-806	83	1	w.m	w.m	PROPN
ajlm-806	83	2	.	.	PROPN
ajlm-806	83	3	and	and	CCONJ
ajlm-806	83	4	m.m	m.m	PROPN
ajlm-806	83	5	.	.	PROPN
ajlm-806	83	6	wrote	write	VERB
ajlm-806	83	7	the	the	DET
ajlm-806	83	8	manuscript	manuscript	NOUN
ajlm-806	83	9	.	.	PUNCT
ajlm-806	84	1	p.d.h	p.d.h	PROPN
ajlm-806	84	2	.	.	PUNCT
ajlm-806	85	1	critically	critically	ADV
ajlm-806	85	2	reviewed	review	VERB
ajlm-806	85	3	the	the	DET
ajlm-806	85	4	manuscript	manuscript	NOUN
ajlm-806	85	5	.	.	PUNCT
ajlm-806	86	1	all	all	DET
ajlm-806	86	2	authors	author	NOUN
ajlm-806	86	3	reviewed	review	VERB
ajlm-806	86	4	and	and	CCONJ
ajlm-806	86	5	approved	approve	VERB
ajlm-806	86	6	the	the	DET
ajlm-806	86	7	final	final	ADJ
ajlm-806	86	8	version	version	NOUN
ajlm-806	86	9	of	of	ADP
ajlm-806	86	10	the	the	DET
ajlm-806	86	11	manuscript	manuscript	NOUN
ajlm-806	86	12	.	.	PUNCT
ajlm-806	87	1	references	reference	NOUN
ajlm-806	87	2	world	world	PROPN
ajlm-806	87	3	health	health	PROPN
ajlm-806	87	4	organization	organization	PROPN
ajlm-806	87	5	.	.	PUNCT
ajlm-806	88	1	policy	policy	NOUN
ajlm-806	88	2	statement	statement	NOUN
ajlm-806	88	3	:	:	PUNCT
ajlm-806	88	4	automated	automate	VERB
ajlm-806	88	5	real	real	ADJ
ajlm-806	88	6	-	-	PUNCT
ajlm-806	88	7	time	time	NOUN
ajlm-806	88	8	nucleic	nucleic	ADJ
ajlm-806	88	9	acid	acid	NOUN
ajlm-806	88	10	amplification	amplification	NOUN
ajlm-806	88	11	technology	technology	NOUN
ajlm-806	88	12	for	for	ADP
ajlm-806	88	13	rapid	rapid	ADJ
ajlm-806	88	14	and	and	CCONJ
ajlm-806	88	15	simultaneous	simultaneous	ADJ
ajlm-806	88	16	detection	detection	NOUN
ajlm-806	88	17	of	of	ADP
ajlm-806	88	18	tuberculosis	tuberculosis	NOUN
ajlm-806	88	19	and	and	CCONJ
ajlm-806	88	20	rifampicin	rifampicin	VERB
ajlm-806	88	21	resistance	resistance	NOUN
ajlm-806	88	22	.	.	PUNCT
ajlm-806	89	1	geneva	geneva	PROPN
ajlm-806	89	2	:	:	PUNCT
ajlm-806	90	1	who	who	PRON
ajlm-806	90	2	;	;	PUNCT
ajlm-806	90	3	2011	2011	NUM
ajlm-806	90	4	.	.	PUNCT
ajlm-806	91	1	world	world	PROPN
ajlm-806	91	2	health	health	PROPN
ajlm-806	91	3	organization	organization	PROPN
ajlm-806	91	4	.	.	PUNCT
ajlm-806	92	1	policy	policy	NOUN
ajlm-806	92	2	statement	statement	NOUN
ajlm-806	92	3	.	.	PUNCT
ajlm-806	93	1	molecular	molecular	ADJ
ajlm-806	93	2	line	line	NOUN
ajlm-806	93	3	probe	probe	NOUN
ajlm-806	93	4	assays	assay	NOUN
ajlm-806	93	5	for	for	ADP
ajlm-806	93	6	rapid	rapid	ADJ
ajlm-806	93	7	screening	screening	NOUN
ajlm-806	93	8	of	of	ADP
ajlm-806	93	9	patients	patient	NOUN
ajlm-806	93	10	at	at	ADP
ajlm-806	93	11	risk	risk	NOUN
ajlm-806	93	12	of	of	ADP
ajlm-806	93	13	multidrug	multidrug	NOUN
ajlm-806	93	14	resistant	resistant	ADJ
ajlm-806	93	15	tuberculosis	tuberculosis	NOUN
ajlm-806	93	16	(	(	PUNCT
ajlm-806	93	17	mdr	mdr	NOUN
ajlm-806	93	18	-	-	NOUN
ajlm-806	93	19	tb	tb	NOUN
ajlm-806	93	20	)	)	PUNCT
ajlm-806	94	1	[	[	X
ajlm-806	94	2	homepage	homepage	NOUN
ajlm-806	94	3	on	on	ADP
ajlm-806	94	4	the	the	DET
ajlm-806	94	5	internet	internet	NOUN
ajlm-806	94	6	]	]	PUNCT
ajlm-806	94	7	.	.	PUNCT
ajlm-806	95	1	[	[	X
ajlm-806	95	2	cited	cite	VERB
ajlm-806	95	3	2008	2008	NUM
ajlm-806	95	4	june	june	PROPN
ajlm-806	95	5	27	27	NUM
ajlm-806	95	6	]	]	PUNCT
ajlm-806	95	7	.	.	PUNCT
ajlm-806	96	1	available	available	ADJ
ajlm-806	96	2	from	from	ADP
ajlm-806	96	3	:	:	PUNCT
ajlm-806	96	4	http://www.who.int/tb/features_archive/policy_statement.pdf	http://www.who.int/tb/features_archive/policy_statement.pdf	NUM
ajlm-806	96	5	siu	siu	PROPN
ajlm-806	96	6	gk	gk	PROPN
ajlm-806	96	7	,	,	PUNCT
ajlm-806	96	8	zhang	zhang	PROPN
ajlm-806	96	9	y	y	PROPN
ajlm-806	96	10	,	,	PUNCT
ajlm-806	96	11	lau	lau	PROPN
ajlm-806	96	12	tck	tck	PROPN
ajlm-806	96	13	,	,	PUNCT
ajlm-806	96	14	et	et	PROPN
ajlm-806	96	15	al	al	PROPN
ajlm-806	96	16	.	.	PUNCT
ajlm-806	96	17	mutations	mutation	NOUN
ajlm-806	96	18	outside	outside	ADP
ajlm-806	96	19	the	the	DET
ajlm-806	96	20	rifampicin	rifampicin	VERB
ajlm-806	96	21	resistance	resistance	NOUN
ajlm-806	96	22	-	-	PUNCT
ajlm-806	96	23	determining	determine	VERB
ajlm-806	96	24	region	region	NOUN
ajlm-806	96	25	associated	associate	VERB
ajlm-806	96	26	with	with	ADP
ajlm-806	96	27	rifampicin	rifampicin	VERB
ajlm-806	96	28	resistance	resistance	NOUN
ajlm-806	96	29	in	in	ADP
ajlm-806	96	30	mycobacterium	mycobacterium	NOUN
ajlm-806	96	31	tuberculosis	tuberculosis	NOUN
ajlm-806	96	32	.	.	PUNCT
ajlm-806	97	1	j	j	PROPN
ajlm-806	97	2	antimicrob	antimicrob	PROPN
ajlm-806	97	3	chemother	chemother	PROPN
ajlm-806	97	4	.	.	PUNCT
ajlm-806	98	1	2011;66(4):730–733	2011;66(4):730–733	X
ajlm-806	98	2	.	.	PUNCT
ajlm-806	99	1	https://doi.org/10.1093/jac/dkq519	https://doi.org/10.1093/jac/dkq519	PROPN
ajlm-806	99	2	jamieson	jamieson	PROPN
ajlm-806	99	3	fb	fb	PROPN
ajlm-806	99	4	,	,	PUNCT
ajlm-806	99	5	guthrie	guthrie	PROPN
ajlm-806	99	6	jl	jl	PROPN
ajlm-806	99	7	,	,	PUNCT
ajlm-806	99	8	neemuchwala	neemuchwala	PROPN
ajlm-806	99	9	a	a	NOUN
ajlm-806	99	10	,	,	PUNCT
ajlm-806	99	11	et	et	PROPN
ajlm-806	99	12	al	al	PROPN
ajlm-806	99	13	.	.	PUNCT
ajlm-806	99	14	profiling	profiling	NOUN
ajlm-806	99	15	of	of	ADP
ajlm-806	99	16	rpob	rpob	ADJ
ajlm-806	99	17	mutations	mutation	NOUN
ajlm-806	99	18	and	and	CCONJ
ajlm-806	99	19	mics	mic	NOUN
ajlm-806	99	20	for	for	ADP
ajlm-806	99	21	rifampin	rifampin	NOUN
ajlm-806	99	22	and	and	CCONJ
ajlm-806	99	23	rifabutin	rifabutin	NOUN
ajlm-806	99	24	in	in	ADP
ajlm-806	99	25	mycobacterium	mycobacterium	NOUN
ajlm-806	99	26	tuberculosis	tuberculosis	NOUN
ajlm-806	99	27	.	.	PUNCT
ajlm-806	100	1	j	j	PROPN
ajlm-806	100	2	clin	clin	PROPN
ajlm-806	100	3	microbiol	microbiol	PROPN
ajlm-806	100	4	.	.	PUNCT
ajlm-806	101	1	2014;52(6):2157–2162	2014;52(6):2157–2162	NUM
ajlm-806	101	2	.	.	PUNCT
ajlm-806	102	1	https://doi.org/10.1128/jcm.00691-14	https://doi.org/10.1128/jcm.00691-14	NOUN
ajlm-806	102	2	horng	horng	ADJ
ajlm-806	102	3	yt	yt	PROPN
ajlm-806	102	4	,	,	PUNCT
ajlm-806	102	5	j	j	PROPN
ajlm-806	102	6	w	w	PROPN
ajlm-806	102	7	-	-	PROPN
ajlm-806	102	8	y	y	PROPN
ajlm-806	102	9	,	,	PUNCT
ajlm-806	102	10	chen	chen	PROPN
ajlm-806	102	11	y	y	PROPN
ajlm-806	102	12	-	-	PROPN
ajlm-806	102	13	y	y	PROPN
ajlm-806	102	14	,	,	PUNCT
ajlm-806	102	15	et	et	PROPN
ajlm-806	102	16	al	al	PROPN
ajlm-806	102	17	.	.	PUNCT
ajlm-806	103	1	molecular	molecular	ADJ
ajlm-806	103	2	analysis	analysis	NOUN
ajlm-806	103	3	of	of	ADP
ajlm-806	103	4	codon	codon	ADJ
ajlm-806	103	5	548	548	NUM
ajlm-806	103	6	in	in	ADP
ajlm-806	103	7	the	the	DET
ajlm-806	103	8	rpob	rpob	ADJ
ajlm-806	103	9	gene	gene	NOUN
ajlm-806	103	10	involved	involve	VERB
ajlm-806	103	11	in	in	ADP
ajlm-806	103	12	mycobacterium	mycobacterium	NOUN
ajlm-806	103	13	tuberculosis	tuberculosis	NOUN
ajlm-806	103	14	resistance	resistance	NOUN
ajlm-806	103	15	to	to	PART
ajlm-806	103	16	rifampin	rifampin	VERB
ajlm-806	103	17	.	.	PUNCT
ajlm-806	104	1	antimicrob	antimicrob	PROPN
ajlm-806	104	2	agents	agents	PROPN
ajlm-806	104	3	chemother	chemother	PROPN
ajlm-806	104	4	.	.	PUNCT
ajlm-806	105	1	2015;59(3):1542–1548	2015;59(3):1542–1548	NUM
ajlm-806	105	2	.	.	PUNCT
ajlm-806	106	1	https://doi.org/10.1128/aac.04374-14	https://doi.org/10.1128/aac.04374-14	PROPN
ajlm-806	106	2	muyoyeta	muyoyeta	PROPN
ajlm-806	106	3	m	m	PROPN
ajlm-806	106	4	,	,	PUNCT
ajlm-806	106	5	moyo	moyo	PROPN
ajlm-806	106	6	m	m	PROPN
ajlm-806	106	7	,	,	PUNCT
ajlm-806	106	8	kasese	kasese	ADJ
ajlm-806	106	9	n	n	CCONJ
ajlm-806	106	10	,	,	PUNCT
ajlm-806	106	11	et	et	PROPN
ajlm-806	106	12	al	al	PROPN
ajlm-806	106	13	.	.	PUNCT
ajlm-806	106	14	implementation	implementation	NOUN
ajlm-806	106	15	research	research	NOUN
ajlm-806	106	16	to	to	PART
ajlm-806	106	17	inform	inform	VERB
ajlm-806	106	18	the	the	DET
ajlm-806	106	19	use	use	NOUN
ajlm-806	106	20	of	of	ADP
ajlm-806	106	21	xpert	xpert	PROPN
ajlm-806	106	22	mtb	mtb	PROPN
ajlm-806	106	23	/	/	SYM
ajlm-806	106	24	rif	rif	PROPN
ajlm-806	106	25	in	in	ADP
ajlm-806	106	26	primary	primary	ADJ
ajlm-806	106	27	health	health	NOUN
ajlm-806	106	28	care	care	NOUN
ajlm-806	106	29	facilities	facility	NOUN
ajlm-806	106	30	in	in	ADP
ajlm-806	106	31	high	high	ADJ
ajlm-806	106	32	tb	tb	NOUN
ajlm-806	107	1	and	and	CCONJ
ajlm-806	107	2	hiv	hiv	PROPN
ajlm-806	107	3	settings	setting	NOUN
ajlm-806	107	4	in	in	ADP
ajlm-806	107	5	resource	resource	NOUN
ajlm-806	107	6	constrained	constrain	VERB
ajlm-806	107	7	settings	setting	NOUN
ajlm-806	107	8	.	.	PUNCT
ajlm-806	108	1	plos	plos	PROPN
ajlm-806	108	2	one	one	NUM
ajlm-806	108	3	.	.	PUNCT
ajlm-806	109	1	2015;10(6):e0126376	2015;10(6):e0126376	X
ajlm-806	109	2	.	.	PROPN
ajlm-806	109	3	https://doi.org/10.1371/journal.pone.0126376	https://doi.org/10.1371/journal.pone.0126376	PROPN
ajlm-806	109	4	muyoyeta	muyoyeta	PROPN
ajlm-806	109	5	m	m	PROPN
ajlm-806	109	6	,	,	PUNCT
ajlm-806	109	7	et	et	PROPN
ajlm-806	109	8	al	al	PROPN
ajlm-806	109	9	.	.	PROPN
ajlm-806	109	10	sensitivity	sensitivity	NOUN
ajlm-806	109	11	,	,	PUNCT
ajlm-806	109	12	specificity	specificity	NOUN
ajlm-806	109	13	,	,	PUNCT
ajlm-806	109	14	and	and	CCONJ
ajlm-806	109	15	reproducibility	reproducibility	NOUN
ajlm-806	109	16	of	of	ADP
ajlm-806	109	17	the	the	DET
ajlm-806	109	18	capilia	capilia	NOUN
ajlm-806	109	19	tb	tb	NOUN
ajlm-806	109	20	-	-	PUNCT
ajlm-806	109	21	neo	neo	NOUN
ajlm-806	109	22	assay	assay	NOUN
ajlm-806	109	23	.	.	PUNCT
ajlm-806	110	1	j	j	PROPN
ajlm-806	110	2	clin	clin	PROPN
ajlm-806	110	3	microbiol	microbiol	PROPN
ajlm-806	110	4	.	.	PUNCT
ajlm-806	111	1	2013;51(12):4237–4239	2013;51(12):4237–4239	NUM
ajlm-806	111	2	.	.	PUNCT
ajlm-806	112	1	https://doi.org/10.1128/jcm.02441-13	https://doi.org/10.1128/jcm.02441-13	PROPN
ajlm-806	112	2	muyoyeta	muyoyeta	PROPN
ajlm-806	112	3	m	m	PROPN
ajlm-806	112	4	,	,	PUNCT
ajlm-806	112	5	mwanza	mwanza	PROPN
ajlm-806	112	6	wc	wc	PROPN
ajlm-806	112	7	,	,	PUNCT
ajlm-806	112	8	kasese	kasese	ADJ
ajlm-806	112	9	n	n	CCONJ
ajlm-806	112	10	,	,	PUNCT
ajlm-806	112	11	et	et	PROPN
ajlm-806	112	12	al	al	PROPN
ajlm-806	112	13	.	.	PUNCT
ajlm-806	112	14	evaluation	evaluation	NOUN
ajlm-806	112	15	of	of	ADP
ajlm-806	112	16	the	the	DET
ajlm-806	112	17	capilia	capilia	NOUN
ajlm-806	112	18	tb	tb	ADP
ajlm-806	112	19	assay	assay	NOUN
ajlm-806	112	20	for	for	ADP
ajlm-806	112	21	culture	culture	NOUN
ajlm-806	112	22	confirmation	confirmation	NOUN
ajlm-806	112	23	of	of	ADP
ajlm-806	112	24	mycobacterium	mycobacterium	NOUN
ajlm-806	112	25	tuberculosis	tuberculosis	NOUN
ajlm-806	112	26	infections	infection	NOUN
ajlm-806	112	27	in	in	ADP
ajlm-806	112	28	zambia	zambia	PROPN
ajlm-806	112	29	and	and	CCONJ
ajlm-806	112	30	south	south	PROPN
ajlm-806	112	31	africa	africa	PROPN
ajlm-806	112	32	.	.	PUNCT
ajlm-806	113	1	j	j	PROPN
ajlm-806	113	2	clin	clin	PROPN
ajlm-806	113	3	microbiol	microbiol	PROPN
ajlm-806	113	4	.	.	PUNCT
ajlm-806	114	1	2010;48(10):3773–3775	2010;48(10):3773–3775	ADJ
ajlm-806	114	2	.	.	PUNCT
ajlm-806	115	1	https://doi.org/10.1128/jcm.01688-09	https://doi.org/10.1128/jcm.01688-09	PROPN
ajlm-806	115	2	hain	hain	PROPN
ajlm-806	115	3	life	life	PROPN
ajlm-806	115	4	sciences	sciences	PROPN
ajlm-806	115	5	.	.	PUNCT
ajlm-806	116	1	genotype	genotype	NOUN
ajlm-806	116	2	mtbdrplus	mtbdrplus	PROPN
ajlm-806	116	3	:	:	PUNCT
ajlm-806	116	4	instructions	instruction	NOUN
ajlm-806	116	5	for	for	ADP
ajlm-806	116	6	use	use	NOUN
ajlm-806	116	7	.	.	PUNCT
ajlm-806	117	1	nehren	nehren	PROPN
ajlm-806	117	2	,	,	PUNCT
ajlm-806	117	3	germany	germany	PROPN
ajlm-806	117	4	:	:	PUNCT
ajlm-806	117	5	hain	hain	PROPN
ajlm-806	117	6	life	life	NOUN
ajlm-806	117	7	sciences	sciences	PROPN
ajlm-806	117	8	.	.	PUNCT
ajlm-806	118	1	kapata	kapata	PROPN
ajlm-806	118	2	n	n	CCONJ
ajlm-806	118	3	,	,	PUNCT
ajlm-806	118	4	chanda	chanda	PROPN
ajlm-806	118	5	-	-	PUNCT
ajlm-806	118	6	kapata	kapata	PROPN
ajlm-806	118	7	p	p	PROPN
ajlm-806	118	8	,	,	PUNCT
ajlm-806	118	9	bates	bates	PROPN
ajlm-806	118	10	m	m	PROPN
ajlm-806	118	11	,	,	PUNCT
ajlm-806	118	12	et	et	PROPN
ajlm-806	118	13	al	al	PROPN
ajlm-806	118	14	.	.	PROPN
ajlm-806	118	15	multidrug	multidrug	NOUN
ajlm-806	118	16	-	-	PUNCT
ajlm-806	118	17	resistant	resistant	ADJ
ajlm-806	118	18	tb	tb	NOUN
ajlm-806	118	19	in	in	ADP
ajlm-806	118	20	zambia	zambia	PROPN
ajlm-806	118	21	:	:	PUNCT
ajlm-806	118	22	review	review	NOUN
ajlm-806	118	23	of	of	ADP
ajlm-806	118	24	national	national	ADJ
ajlm-806	118	25	data	datum	NOUN
ajlm-806	118	26	from	from	ADP
ajlm-806	118	27	2000	2000	NUM
ajlm-806	118	28	to	to	ADP
ajlm-806	118	29	2011	2011	NUM
ajlm-806	118	30	.	.	PUNCT
ajlm-806	119	1	trop	trop	PROPN
ajlm-806	119	2	med	med	ADJ
ajlm-806	119	3	int	int	PROPN
ajlm-806	119	4	health	health	NOUN
ajlm-806	119	5	.	.	PUNCT
ajlm-806	120	1	2013;18(11):1386–1391	2013;18(11):1386–1391	X
ajlm-806	120	2	.	.	PUNCT
ajlm-806	121	1	https://doi.org/10.1111/tmi.12183	https://doi.org/10.1111/tmi.12183	PROPN
ajlm-806	121	2	steingart	steingart	PROPN
ajlm-806	121	3	kr	kr	PROPN
ajlm-806	121	4	,	,	PUNCT
ajlm-806	121	5	schiller	schiller	NOUN
ajlm-806	121	6	i	i	PROPN
ajlm-806	121	7	,	,	PUNCT
ajlm-806	121	8	horne	horne	PROPN
ajlm-806	121	9	dj	dj	PROPN
ajlm-806	121	10	,	,	PUNCT
ajlm-806	121	11	et	et	PROPN
ajlm-806	121	12	al	al	PROPN
ajlm-806	121	13	.	.	PROPN
ajlm-806	122	1	xpert(r	xpert(r	NUM
ajlm-806	122	2	)	)	PUNCT
ajlm-806	122	3	mtb	mtb	PROPN
ajlm-806	122	4	/	/	SYM
ajlm-806	122	5	rif	rif	PROPN
ajlm-806	122	6	assay	assay	NOUN
ajlm-806	122	7	for	for	ADP
ajlm-806	122	8	pulmonary	pulmonary	ADJ
ajlm-806	122	9	tuberculosis	tuberculosis	NOUN
ajlm-806	122	10	and	and	CCONJ
ajlm-806	122	11	rifampicin	rifampicin	VERB
ajlm-806	122	12	resistance	resistance	NOUN
ajlm-806	122	13	in	in	ADP
ajlm-806	122	14	adults	adult	NOUN
ajlm-806	122	15	.	.	PUNCT
ajlm-806	123	1	cochrane	cochrane	NOUN
ajlm-806	123	2	database	database	PROPN
ajlm-806	123	3	syst	syst	PROPN
ajlm-806	123	4	rev	rev	PROPN
ajlm-806	123	5	.	.	PROPN
ajlm-806	124	1	2014;1	2014;1	NUM
ajlm-806	124	2	:	:	PUNCT
ajlm-806	124	3	cd009593	cd009593	PROPN
ajlm-806	124	4	.	.	PUNCT
ajlm-806	125	1	marlowe	marlowe	VERB
ajlm-806	125	2	em	em	PRON
ajlm-806	125	3	,	,	PUNCT
ajlm-806	125	4	novak	novak	PROPN
ajlm-806	125	5	-	-	PUNCT
ajlm-806	125	6	weekley	weekley	PROPN
ajlm-806	125	7	sm	sm	PROPN
ajlm-806	125	8	,	,	PUNCT
ajlm-806	125	9	cumpio	cumpio	PROPN
ajlm-806	125	10	j	j	PROPN
ajlm-806	125	11	,	,	PUNCT
ajlm-806	125	12	et	et	PROPN
ajlm-806	125	13	al	al	PROPN
ajlm-806	125	14	.	.	PUNCT
ajlm-806	125	15	evaluation	evaluation	NOUN
ajlm-806	125	16	of	of	ADP
ajlm-806	125	17	the	the	DET
ajlm-806	125	18	cepheid	cepheid	PROPN
ajlm-806	125	19	xpert	xpert	PROPN
ajlm-806	125	20	mtb	mtb	PROPN
ajlm-806	125	21	/	/	SYM
ajlm-806	125	22	rif	rif	PROPN
ajlm-806	125	23	assay	assay	NOUN
ajlm-806	125	24	for	for	ADP
ajlm-806	125	25	direct	direct	ADJ
ajlm-806	125	26	detection	detection	NOUN
ajlm-806	125	27	of	of	ADP
ajlm-806	125	28	mycobacterium	mycobacterium	NOUN
ajlm-806	125	29	tuberculosis	tuberculosis	NOUN
ajlm-806	125	30	complex	complex	NOUN
ajlm-806	125	31	in	in	ADP
ajlm-806	125	32	respiratory	respiratory	ADJ
ajlm-806	125	33	specimens	specimen	NOUN
ajlm-806	125	34	.	.	PUNCT
ajlm-806	126	1	j	j	PROPN
ajlm-806	126	2	clin	clin	PROPN
ajlm-806	126	3	microbiol	microbiol	PROPN
ajlm-806	126	4	.	.	PUNCT
ajlm-806	127	1	2011;49(4):1621–1623	2011;49(4):1621–1623	NUM
ajlm-806	127	2	.	.	PUNCT
ajlm-806	128	1	https://doi.org/10.1128/jcm.02214-10	https://doi.org/10.1128/jcm.02214-10	NOUN
ajlm-806	128	2	claessens	claessen	VERB
ajlm-806	128	3	j	j	PROPN
ajlm-806	128	4	,	,	PUNCT
ajlm-806	128	5	mathys	mathy	NOUN
ajlm-806	128	6	v	v	ADP
ajlm-806	128	7	,	,	PUNCT
ajlm-806	128	8	derdelinckx	derdelinckx	NOUN
ajlm-806	128	9	i	i	PRON
ajlm-806	128	10	,	,	PUNCT
ajlm-806	128	11	saegeman	saegeman	PROPN
ajlm-806	128	12	v.	v.	ADP
ajlm-806	128	13	case	case	NOUN
ajlm-806	128	14	report	report	NOUN
ajlm-806	128	15	of	of	ADP
ajlm-806	128	16	a	a	DET
ajlm-806	128	17	false	false	ADJ
ajlm-806	128	18	positive	positive	ADJ
ajlm-806	128	19	result	result	NOUN
ajlm-806	128	20	of	of	ADP
ajlm-806	128	21	the	the	DET
ajlm-806	128	22	xpert(r	xpert(r	PROPN
ajlm-806	128	23	)	)	PUNCT
ajlm-806	128	24	mtb	mtb	PROPN
ajlm-806	128	25	/	/	SYM
ajlm-806	128	26	rif	rif	PROPN
ajlm-806	128	27	assay	assay	NOUN
ajlm-806	128	28	for	for	ADP
ajlm-806	128	29	rifampicin	rifampicin	VERB
ajlm-806	128	30	resistance	resistance	NOUN
ajlm-806	128	31	in	in	ADP
ajlm-806	128	32	mycobacterium	mycobacterium	NOUN
ajlm-806	128	33	tuberculosis	tuberculosis	NOUN
ajlm-806	128	34	complex	complex	NOUN
ajlm-806	128	35	.	.	PUNCT
ajlm-806	129	1	acta	acta	PROPN
ajlm-806	129	2	clin	clin	PROPN
ajlm-806	129	3	belg	belg	PROPN
ajlm-806	129	4	.	.	PUNCT
ajlm-806	130	1	2017	2017	NUM
ajlm-806	130	2	jun;72(3):195–197	jun;72(3):195–197	NOUN
ajlm-806	130	3	.	.	PUNCT
ajlm-806	131	1	doi	doi	NOUN
ajlm-806	131	2	:	:	PUNCT
ajlm-806	131	3	10.1179/2295333715y.0000000072	10.1179/2295333715y.0000000072	NUM
ajlm-806	131	4	.	.	PUNCT
ajlm-806	132	1	mathys	mathy	NOUN
ajlm-806	132	2	v	v	ADP
ajlm-806	132	3	,	,	PUNCT
ajlm-806	132	4	van	van	PROPN
ajlm-806	132	5	de	de	PROPN
ajlm-806	132	6	vyvere	vyvere	PROPN
ajlm-806	132	7	m	m	PROPN
ajlm-806	132	8	,	,	PUNCT
ajlm-806	132	9	de	de	X
ajlm-806	132	10	droogh	droogh	X
ajlm-806	132	11	e	e	NOUN
ajlm-806	132	12	,	,	PUNCT
ajlm-806	132	13	soetaert	soetaert	PROPN
ajlm-806	132	14	k	k	PROPN
ajlm-806	132	15	,	,	PUNCT
ajlm-806	132	16	groenen	groenen	PROPN
ajlm-806	132	17	g.	g.	PROPN
ajlm-806	132	18	false	false	ADJ
ajlm-806	132	19	-	-	PUNCT
ajlm-806	132	20	positive	positive	ADJ
ajlm-806	132	21	rifampicin	rifampicin	VERB
ajlm-806	132	22	resistance	resistance	NOUN
ajlm-806	132	23	on	on	ADP
ajlm-806	132	24	xpert(r	xpert(r	PROPN
ajlm-806	132	25	)	)	PUNCT
ajlm-806	132	26	mtb	mtb	PROPN
ajlm-806	132	27	/	/	SYM
ajlm-806	132	28	rif	rif	PROPN
ajlm-806	132	29	caused	cause	VERB
ajlm-806	132	30	by	by	ADP
ajlm-806	132	31	a	a	DET
ajlm-806	132	32	silent	silent	ADJ
ajlm-806	132	33	mutation	mutation	NOUN
ajlm-806	132	34	in	in	ADP
ajlm-806	132	35	the	the	DET
ajlm-806	132	36	rpob	rpob	ADJ
ajlm-806	132	37	gene	gene	NOUN
ajlm-806	132	38	.	.	PUNCT
ajlm-806	133	1	int	int	PROPN
ajlm-806	133	2	j	j	PROPN
ajlm-806	133	3	tuberc	tuberc	PROPN
ajlm-806	133	4	lung	lung	PROPN
ajlm-806	133	5	dis	dis	PROPN
ajlm-806	133	6	.	.	PUNCT
ajlm-806	134	1	2014;18(10):1255–1257	2014;18(10):1255–1257	PROPN
ajlm-806	134	2	.	.	PUNCT
ajlm-806	135	1	https://doi.org/10.5588/ijtld.14.0297	https://doi.org/10.5588/ijtld.14.0297	PROPN
ajlm-806	135	2	alonso	alonso	PROPN
ajlm-806	135	3	m	m	PROPN
ajlm-806	135	4	,	,	PUNCT
ajlm-806	135	5	palacios	palacios	PROPN
ajlm-806	135	6	jj	jj	PROPN
ajlm-806	135	7	,	,	PUNCT
ajlm-806	135	8	herrantz	herrantz	ADJ
ajlm-806	135	9	m	m	PROPN
ajlm-806	135	10	,	,	PUNCT
ajlm-806	135	11	et	et	PROPN
ajlm-806	135	12	al	al	PROPN
ajlm-806	135	13	.	.	PUNCT
ajlm-806	135	14	isolation	isolation	NOUN
ajlm-806	135	15	of	of	ADP
ajlm-806	135	16	mycobacterium	mycobacterium	NOUN
ajlm-806	135	17	tuberculosis	tuberculosis	NOUN
ajlm-806	135	18	strains	strain	VERB
ajlm-806	135	19	with	with	ADP
ajlm-806	135	20	a	a	DET
ajlm-806	135	21	silent	silent	ADJ
ajlm-806	135	22	mutation	mutation	NOUN
ajlm-806	135	23	in	in	ADP
ajlm-806	135	24	rpob	rpob	PROPN
ajlm-806	135	25	leading	lead	VERB
ajlm-806	135	26	to	to	ADP
ajlm-806	135	27	potential	potential	ADJ
ajlm-806	135	28	misassignment	misassignment	NOUN
ajlm-806	135	29	of	of	ADP
ajlm-806	135	30	resistance	resistance	NOUN
ajlm-806	135	31	category	category	NOUN
ajlm-806	135	32	.	.	PUNCT
ajlm-806	136	1	j	j	PROPN
ajlm-806	136	2	clin	clin	PROPN
ajlm-806	136	3	microbiol	microbiol	PROPN
ajlm-806	136	4	.	.	PUNCT
ajlm-806	137	1	2011;49(7):2688–2690	2011;49(7):2688–2690	NOUN
ajlm-806	137	2	.	.	PUNCT
ajlm-806	138	1	https://doi.org/10.1128/jcm.00659-11	https://doi.org/10.1128/jcm.00659-11	PROPN
ajlm-806	138	2	williamson	williamson	PROPN
ajlm-806	138	3	da	da	PROPN
ajlm-806	138	4	,	,	PUNCT
ajlm-806	138	5	basu	basu	PROPN
ajlm-806	138	6	i	i	PROPN
ajlm-806	138	7	,	,	PUNCT
ajlm-806	138	8	bower	bower	PROPN
ajlm-806	138	9	j	j	PROPN
ajlm-806	138	10	,	,	PUNCT
ajlm-806	138	11	freeman	freeman	PROPN
ajlm-806	138	12	jt	jt	PROPN
ajlm-806	138	13	,	,	PUNCT
ajlm-806	138	14	henderson	henderson	PROPN
ajlm-806	138	15	g	g	PROPN
ajlm-806	138	16	,	,	PUNCT
ajlm-806	138	17	roberts	roberts	PROPN
ajlm-806	138	18	sa	sa	PROPN
ajlm-806	138	19	.	.	PUNCT
ajlm-806	139	1	an	an	DET
ajlm-806	139	2	evaluation	evaluation	NOUN
ajlm-806	139	3	of	of	ADP
ajlm-806	139	4	the	the	DET
ajlm-806	139	5	xpert	xpert	PROPN
ajlm-806	139	6	mtb	mtb	PROPN
ajlm-806	139	7	/	/	SYM
ajlm-806	139	8	rif	rif	PROPN
ajlm-806	139	9	assay	assay	NOUN
ajlm-806	139	10	and	and	CCONJ
ajlm-806	139	11	detection	detection	NOUN
ajlm-806	139	12	of	of	ADP
ajlm-806	139	13	false	false	ADJ
ajlm-806	139	14	-	-	PUNCT
ajlm-806	139	15	positive	positive	ADJ
ajlm-806	139	16	rifampicin	rifampicin	VERB
ajlm-806	139	17	resistance	resistance	NOUN
ajlm-806	139	18	in	in	ADP
ajlm-806	139	19	mycobacterium	mycobacterium	NOUN
ajlm-806	139	20	tuberculosis	tuberculosis	NOUN
ajlm-806	139	21	.	.	PUNCT
ajlm-806	140	1	diagn	diagn	PROPN
ajlm-806	140	2	microbiol	microbiol	PROPN
ajlm-806	140	3	infect	infect	VERB
ajlm-806	140	4	dis	dis	PROPN
ajlm-806	140	5	.	.	PUNCT
ajlm-806	141	1	2012;74(2):207–209	2012;74(2):207–209	X
ajlm-806	141	2	.	.	PUNCT
ajlm-806	142	1	https://doi.org/10.1016/j.diagmicrobio.2012.06.013	https://doi.org/10.1016/j.diagmicrobio.2012.06.013	NUM
ajlm-806	142	2	ocheretina	ocheretina	ADJ
ajlm-806	142	3	o	o	NOUN
ajlm-806	142	4	,	,	PUNCT
ajlm-806	142	5	byrt	byrt	PROPN
ajlm-806	142	6	e	e	PROPN
ajlm-806	142	7	,	,	PUNCT
ajlm-806	142	8	mabou	mabou	PROPN
ajlm-806	142	9	m	m	PROPN
ajlm-806	142	10	-	-	PROPN
ajlm-806	142	11	m	m	PROPN
ajlm-806	142	12	,	,	PUNCT
ajlm-806	142	13	et	et	PROPN
ajlm-806	142	14	al	al	PROPN
ajlm-806	142	15	.	.	PUNCT
ajlm-806	143	1	false	false	ADJ
ajlm-806	143	2	-	-	PUNCT
ajlm-806	143	3	positive	positive	ADJ
ajlm-806	143	4	rifampin	rifampin	NOUN
ajlm-806	143	5	resistant	resistant	ADJ
ajlm-806	143	6	results	result	NOUN
ajlm-806	143	7	with	with	ADP
ajlm-806	143	8	xpert	xpert	PROPN
ajlm-806	143	9	mtb	mtb	PROPN
ajlm-806	143	10	/	/	SYM
ajlm-806	143	11	rif	rif	PROPN
ajlm-806	143	12	version	version	PROPN
ajlm-806	143	13	4	4	NUM
ajlm-806	143	14	assay	assay	ADV
ajlm-806	143	15	in	in	ADP
ajlm-806	143	16	clinical	clinical	ADJ
ajlm-806	143	17	samples	sample	NOUN
ajlm-806	143	18	with	with	ADP
ajlm-806	143	19	a	a	DET
ajlm-806	143	20	low	low	ADJ
ajlm-806	143	21	bacterial	bacterial	ADJ
ajlm-806	143	22	load	load	NOUN
ajlm-806	143	23	.	.	PUNCT
ajlm-806	144	1	diagn	diagn	PROPN
ajlm-806	144	2	microbiol	microbiol	PROPN
ajlm-806	144	3	infect	infect	VERB
ajlm-806	144	4	dis	dis	PROPN
ajlm-806	144	5	.	.	PUNCT
ajlm-806	145	1	2016;85(1):53–55	2016;85(1):53–55	X
ajlm-806	145	2	.	.	PUNCT
ajlm-806	146	1	https://doi.org/10.1016/j.diagmicrobio.2016.01.009	https://doi.org/10.1016/j.diagmicrobio.2016.01.009	PROPN
ajlm-806	146	2	n’guessan	n’guessan	PROPN
ajlm-806	146	3	k	k	PROPN
ajlm-806	146	4	,	,	PUNCT
ajlm-806	146	5	assi	assi	PROPN
ajlm-806	146	6	js	js	PROPN
ajlm-806	146	7	,	,	PUNCT
ajlm-806	146	8	ouassa	ouassa	PROPN
ajlm-806	146	9	t	t	PROPN
ajlm-806	146	10	,	,	PUNCT
ajlm-806	146	11	et	et	PROPN
ajlm-806	146	12	al	al	PROPN
ajlm-806	146	13	.	.	PROPN
ajlm-806	146	14	assessment	assessment	NOUN
ajlm-806	146	15	of	of	ADP
ajlm-806	146	16	the	the	DET
ajlm-806	146	17	genotype	genotype	NOUN
ajlm-806	146	18	mtbdrplus	mtbdrplus	ADJ
ajlm-806	146	19	assay	assay	NOUN
ajlm-806	146	20	for	for	ADP
ajlm-806	146	21	rifampin	rifampin	NOUN
ajlm-806	146	22	and	and	CCONJ
ajlm-806	146	23	isoniazid	isoniazid	VERB
ajlm-806	146	24	resistance	resistance	NOUN
ajlm-806	146	25	detection	detection	NOUN
ajlm-806	146	26	on	on	ADP
ajlm-806	146	27	sputum	sputum	NOUN
ajlm-806	146	28	samples	sample	NOUN
ajlm-806	146	29	in	in	ADP
ajlm-806	146	30	cote	cote	PROPN
ajlm-806	146	31	d’ivoire	d’ivoire	PROPN
ajlm-806	146	32	.	.	PUNCT
ajlm-806	147	1	eur	eur	PROPN
ajlm-806	147	2	j	j	PROPN
ajlm-806	147	3	microbiol	microbiol	PROPN
ajlm-806	147	4	immunol	immunol	NOUN
ajlm-806	147	5	(	(	PUNCT
ajlm-806	147	6	bp	bp	PROPN
ajlm-806	147	7	)	)	PUNCT
ajlm-806	147	8	.	.	PUNCT
ajlm-806	148	1	2014;4(3):166–173	2014;4(3):166–173	NUM
ajlm-806	148	2	.	.	PUNCT
ajlm-806	148	3	https://doi.org/10.1556/eujmi-d-14-00014	https://doi.org/10.1556/eujmi-d-14-00014	PROPN
ajlm-806	148	4	ocheretina	ocheretina	PROPN
ajlm-806	148	5	o	o	PROPN
ajlm-806	148	6	,	,	PUNCT
ajlm-806	148	7	escuyer	escuyer	PROPN
ajlm-806	148	8	ve	ve	PROPN
ajlm-806	148	9	,	,	PUNCT
ajlm-806	148	10	mabou	mabou	PROPN
ajlm-806	148	11	m	m	PROPN
ajlm-806	148	12	-	-	PROPN
ajlm-806	148	13	m	m	PROPN
ajlm-806	148	14	,	,	PUNCT
ajlm-806	148	15	et	et	PROPN
ajlm-806	148	16	al	al	PROPN
ajlm-806	148	17	.	.	PROPN
ajlm-806	148	18	correlation	correlation	NOUN
ajlm-806	148	19	between	between	ADP
ajlm-806	148	20	genotypic	genotypic	NOUN
ajlm-806	148	21	and	and	CCONJ
ajlm-806	148	22	phenotypic	phenotypic	ADJ
ajlm-806	148	23	testing	testing	NOUN
ajlm-806	148	24	for	for	ADP
ajlm-806	148	25	resistance	resistance	NOUN
ajlm-806	148	26	to	to	PART
ajlm-806	148	27	rifampin	rifampin	VERB
ajlm-806	148	28	in	in	ADP
ajlm-806	148	29	mycobacterium	mycobacterium	NOUN
ajlm-806	149	1	tuberculosis	tuberculosis	NOUN
ajlm-806	149	2	clinical	clinical	ADJ
ajlm-806	149	3	isolates	isolate	NOUN
ajlm-806	149	4	in	in	ADP
ajlm-806	149	5	haiti	haiti	PROPN
ajlm-806	149	6	:	:	PUNCT
ajlm-806	150	1	investigation	investigation	NOUN
ajlm-806	150	2	of	of	ADP
ajlm-806	150	3	cases	case	NOUN
ajlm-806	150	4	with	with	ADP
ajlm-806	150	5	discrepant	discrepant	NOUN
ajlm-806	150	6	susceptibility	susceptibility	NOUN
ajlm-806	150	7	results	result	NOUN
ajlm-806	150	8	.	.	PUNCT
ajlm-806	151	1	plos	plos	PROPN
ajlm-806	151	2	one	one	NUM
ajlm-806	151	3	.	.	PUNCT
ajlm-806	152	1	2014;9(3):e90569	2014;9(3):e90569	X
ajlm-806	152	2	.	.	PUNCT
ajlm-806	153	1	https://doi.org/10.1371/journal.pone.0090569	https://doi.org/10.1371/journal.pone.0090569	PROPN